Effects of Oxidative Stress on the Expression and Function of Inducible Nitric Oxide Synthase in Cultured Vascular Smooth Muscle Cells by Bingi, Praveen
Effects of Oxidative Stress on the 
Expression and Function of Inducible 
Nitric Oxide Synthase (iNOS) in Cultured 
Vascular Smooth Muscle Cells 
Praveen Kumar Bingi 
University of Hertfordshire 
April 2015 
A thesis submitted to the department of human and 
environmental sciences of University of Hertfordshire in 
partial fulfilment of the requirements for the degree of 
Doctor of Philosophy (PhD) 
 II 
Summary 
 
Atherosclerosis is widely accepted as an inflammatory disease and most common 
cause for the cardiovascular diseases. It is a progressive and multi-factorial disease 
and is presently the foremost cause of morbidity and mortality in the developed world 
(Wong et al., 2006). There are many risk factors such as hypercholesterolemia, 
diabetes, smoking, high fat diet, obesity, infections and age that stimulate 
inflammatory reactions and instigate injury to the endothelium lining the arteries. This 
causes endothelial dysfunction and allows lipids and toxins to enter the intima 
through the damaged endothelial layer. This leads to oxidation of lipids and 
inflammation, which results in plaque deposits, and increased production of reactive 
oxygen species (ROS) causing oxidative stress (OS). The latter are critical in the 
pathogenesis of atherosclerosis and produced as a consequence of the disease 
state (Vogiatzi et al., 2009).  
 
Oxidative stress is defined as an imbalance in the levels of pro-oxidants and anti-
oxidants initiating the accumulation of reactive oxygen species (ROS) such as 
superoxide anion (O2
-),hydroxyl radical (OH-)and hydrogen peroxide (H2O2). 
Oxidative stress causes damage to the vascular lining through mitochondrial 
dysfunctionleading to impairment of cellular functions and contributes to the 
development of diseases including atherosclerosis. In addition, ROS generation may 
lead to decrease in the bioavailability of nitric oxide (NO), leading to platelet 
aggregation and vasoconstriction (Ginnan et al., 2008); and may also enhance 
proliferation and migration of smooth muscle cells while inducing apoptosis of 
endothelial cells as well as causing oxidation of lipids and alteration of vasomotor 
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activity (Valko et al., 2005). Mitochondrial damage causes over production of ROS 
and causes imbalance in the levels of pro-oxidants and anti-oxidants leading to 
apoptosis and atherogenesis. The excessive ROS generated then react with NO 
leading to the formation of peroxynitrite (ONOO-), which is detrimental to the 
vascular endothelium lining (Zhang et al., 2012). In contrast to constitutive NO 
production, excess production of NO by inducible nitric oxide synthase (iNOS) may 
be pathologically relevant in the pathogenesis of atherosclerosis. However the role of 
iNOS in atherosclerosis remains elusive. Whilst it is widely believed to contribute to 
the pathogenesis of the disease, recent studies have shown that iNOS induced nitric 
oxide (NO) has cardio-protective properties, which could restrict the progression of 
atherosclerotic lesions (Kanno et al., 2000; Okazaki et al., 2011). Our previous 
studies have demonstrated that the expression and function of iNOS may be 
selectively down regulated by pro-oxidants such as antimycin A (AA) and diethyl 
maleate (DEM) suggesting that part of the detrimental consequences to OS in the 
disease state may be associated with the obliteration of the iNOS and thus abolition 
of its cardio-protective properties. Intriguingly hydrogen peroxide (H2O2), another 
common pro-oxidant, did not affect iNOS expression and function, indicating that the 
observations we made earlier may not simply be due to OS alone. The effects of OS 
inducers on the expression and function of iNOS could be reversed with atorvastatin. 
To further explore the underlying mechanisms associated with these effects we have 
investigated whether AA and/or DEM modulated the activation of key cellular 
signalling molecules associated with the induction of iNOS, and whether atorvastatin 
exerted any novel actions through these signalling pathways.  
 
 IV 
Rat cultured aortic smooth muscle cells (RASMCs) were treated for 24h with 
antimycin A (25-150µM) or DEM (1-10µM) or H2O2 (25-300µM) 30 min prior to 
stimulation with bacterial lipopolysaccharide (LPS; 100µg ml-1) and interferon-
gamma (IFN-; 100U ml-1). When used, atorvastatin (1-30μM) was added 30 min 
prior to each of these compounds. In experiments with the determination of ROS, 
cells were treated with antimycin A (25-150µM) or DEM (1-10µM) or H2O2 (25-
300µM) for 24h before incubating the cells with a fluoregenic dye. Experiments were 
also conducted using polyethylene-glycol superoxide dismutase (PEG-SOD) and 
polyethylene-glycol catalase (PEG-Catalase) in the presence of OS inducers on 
changes in iNOS expression and/or function and superoxide radical generation. 
When used, cells were incubated with PEG-SOD 500 U/ml or PEG-Catalase 500 
U/ml 30min prior to activation of cells with LPS and IFN-. Nitrite production was 
determined by the Griess assay and total cell protein by the bicinchoninic acid assay. 
Amount of reactive radical species generated was estimated using confocal laser 
scanning microscopy and changes in iNOS expression or phosphorylation of 
mitogen activated protein kinases (MAPK) were determined by western blotting and 
quantified densitometrically using the image-J software. Statistical analysis was 
carried out using one-way ANOVA followed by Bonferroni post-hoc test using Graph 
Pad Prism 5.0.  
 
Antimycin A and DEM resulted in concentration dependent inhibition of NO 
production and iNOS expression (p<0.001) whereas H2O2 was without any effect. 
Antimycin A, H2O2 and DEM induced ROS production in a concentration and time 
dependent manner (p<0.001) but AA and DEM caused more generation of 
superoxide radicals (p<0.001) than did H2O2 which generated mostly hydroxyl 
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radicals. Polyethylene-glycol superoxide dismutase but not PEG-Catalase at a 
concentration of 500 U/ml was able to inhibit the superoxide radical generated by 
antimycin A and DEM (p<0.05). Atorvastatin enhanced nitrite production and iNOS 
expression (p<0.01) in a concentration dependent manner reaching a peak at 10µM 
and considerably declining thereafter. Hence further experiments were continued 
using atorvastatin 10µM. Atorvastatin at 10µM significantly (p<0.001) and PEG-SOD 
(500U ml-1) partially reversed the inhibition of NO production and iNOS expression 
caused by OS inducers. PEG-CAT (500U ml-1) did not affect the inhibitions initiated 
by OS inducers either on iNOS expression/function and superoxide radical 
production. These findings suggest that iNOS expression and nitrite production may 
be down regulated, in part; by pro-oxidants generating superoxide but not hydroxyl 
radicals and this could explain the differential regulation of these processes by the 
different OS inducing agents.  
 
Antimycin A and DEM caused concentration dependent inhibition (p<0.001) of the 
phosphorylation of p38 MAPK and Akt. These changes could be prevented when 
pre-incubated with 10µM atorvastatin (DEM: p<0.01; antimycin A: p<0.05). Thus the 
presence of OS within the vasculature may suppress the expression of iNOS through 
the regulation of either p38 MAPK and/or Akt, which may be prevented with 
atorvastatin. Hence these findings suggest antimycin A and DEM down regulate 
iNOS expression and NO production through inhibition of phosphorylation of p38 
MAPK and Akt. Taken together, the data suggest novel actions for both pro-oxidants 
and atorvastatin, which may have important implications in coronary artery disease 
where suppression of iNOS may be deleterious and maintaining its expression may 
be cardio-protective. 
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Abstract 
The role of inducible nitric oxide synthase (iNOS) and/or nitric oxide (NO) in 
atherosclerosis remains elusive. Several researchers argued whether iNOS and/or 
NO are pathogenic or cardio protective. The pathogenesis of atherosclerosis is 
complex and includes mechanisms associated with inducible nitric oxide synthase 
(iNOS). We have demonstrated that the expression and function of iNOS may be 
selectively down regulated by pro-oxidants such as antimycin A and diethyl maleate 
(DEM). To further explore the underlying mechanisms associated with these effects 
we have investigated whether antimycin A and/or DEM modulated the activation of 
key cellular signalling molecules associated with the induction of iNOS. Expression 
of p38 mitogen activated kinase (MAPK) and Akt were induced by exposure to 
lipopolysaccharide (LPS) and interferon-gamma (IFN-). Oxidative stress (OS) was 
induced using antimycin A, DEM and hydrogen peroxide (H2O2). All three OS 
inducers caused a significant generation of free radicals whereas only antimycin A 
and DEM generated superoxide radical (O2
-). Also nitrite production and iNOS 
expression may be down regulated, in part; by pro-oxidants generating O2
- but not 
hydroxyl radicals (OH-). Antimycin A and DEM concentration dependently inhibited 
the phosphorylation of p38 MAPK and Akt and this was restored when the cells were 
pre-treated with Atorvastatin whereas H2O2 was without any significant effect. Taken 
together, the data suggest novel actions for both pro-oxidants and atorvastatin which 
may have important implications in coronary artery disease where suppression of 
iNOS may be deleterious and maintaining its expression may be cardio-protective. 
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1.0 INTRODUCTION 
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Atherosclerosis is a complex disease with many facets of which the development of 
oxidative stress (OS) and impaired vascular tone linked to reduced production of 
nitric oxide (NO) by the endothelial nitric oxide synthase (eNOS)are a common 
feature. In addition, it has also been widely accepted that overproduction of NO by 
the inducible nitric oxide synthase (iNOS) under conditions of OS contributes to the 
pathogenesis of atherosclerosis. This notion, which ascribes a pathological role for 
iNOS, is however being challenged and iNOS, rather than being pathological, is 
gaining rapid acceptance as a key cardio protective pathway in 
atherosclerosis.Moreover, previous research in our group has demonstrated that OS 
down regulates the expression of the inducible L-arginine-NO pathway which has led 
to the hypothesis that the deleterious effect of OS may be mediated, in part, through 
suppression and loss of the protective and beneficial effects ofiNOS,thereby 
contributing to the pathogenesis of atherosclerosis. This has been further addressed 
in this thesis, which has also been extended to examine whether statins, widely used 
as lipid-lowering drugs, protected against OS induced regulation of iNOS through 
novel mechanisms that may be independent of their lipid lowering effects. 
 
1.1 Atherosclerosis 
Atherosclerosis is the most common and typical cause of heart attacks, strokes and 
peripheral vascular disease. It is a progressive and multi-factorial disease and is 
currently the leading cause of morbidityand mortality in the developed world (Wong 
et al., 2006). No less than 2.6 million people in the United Kingdom suffer from the 
disease (http://www.bhf.org.uk/heart-matters-online/may-june-2013/medical/ 
atherosclerosis.aspx). The epidemiological studies conducted previously stressed 
upon the importance of environmental and genetic risk factors in association with 
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atherosclerosis. However the complexity of the disease aetiology made it difficult to 
understand the cellular and molecular interactions. 
 
Atherosclerosis was initially considered to be simply a disorder of lipid deposition 
leading to myocardial infarction, stroke and ischemic gangrene (Hansson et al., 
2006). It is, however, now known to be an immune-inflammatory disease where 
lipids, leukocytes and smooth muscle cellsas well ascholesterol-engorged 
macrophages or foam cells accruein the intima of the arteries (Zhou & Liao, 2009) 
leading to the formation of fibro fattyplaquescalled atheroma. This material gradually 
encroaches into the lumen of the vessel, eventually leading to blockage of the artery. 
Plaques may be formed which can weaken the wall of the artery leading to aneurysm 
and could also cause narrowing of the arteries, thus restricting blood flow (Davis, 
2005).This in turn may lead to angina pectoris (chest pain) and subsequently 
myocardial infarction, heart attack and death. 
 
The difference in dynamics of blood flow allows the lesions to be formed at distinct 
sites inside the arteries and these tend to be regions of high shear. In the early stage 
of the disease, lipid laden foam cells form fatty streaks which are not clinically 
substantial, but the accumulation of smooth muscle cells (SMCs) and lipid rich 
necrotic debris lead to significant lesions (Coller, 2005). A fibrous cap consisting of 
monocytes, macrophages and extracellular matrix that enclose a lipid-rich necrotic 
core characterizes these stringy lesions. These plaques are further hardened and 
increased by the accumulating through calcification, ulceration and also hemorrhage 
from small vessels that lead to lesions from media of the blood vessel wall. (Figure 
1) (Moore & Tabas, 2011). 
 4 
 
Figure 1.1A diagrammatic representation of stages of atherosclerosis taken 
from http://www.educatehealth.ca/patient/heart/heart-attack.aspx 
 
 
The trigger for the development of atherosclerosis is now widely accepted to be 
associated with endothelial dysfunction (Hadi et al., 2005). Indeed many risk factors 
such as hypercholesterolemia, diabetes, smoking, high fat diet, obesity, infections 
and age promote inflammatory reactions and OS causing damage to the 
endothelium lining the arteries (Rasmussen et al., 2005). This causes endothelial 
dysfunction and allows lipids to enter the intima through the damaged endothelial 
layer. In parallel, there is also increased recruitment of circulating monocytes, which 
differentiate into macrophages once in the intima. The macrophages in turn 
accumulate oxidised low density lipoproteins (Ox-LDL) generated from the oxidation 
of LDL by reactive oxygen species (ROS). The latter are critical in the pathogenesis 
of atherosclerosis and are produced as a consequence of the disease state(Vogiatzi 
et al., 2009).  
 
Healthy Artery 
Formation of Plaque 
Deposition begins 
Plaque Rupture 
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1.2 Oxidative Stress 
Oxidative stress is defined as an imbalance in the levels of pro-oxidants and anti-
oxidants in the biological system (Nedeljkovicet al., 2003). It arises when there is an 
increase in pro-oxidants thereby releasing more amounts of free radicals within the 
cells (Gobe & Crane, 2010). The biological system loses the capacity to neutralise 
excess free radicals, which in turn cause complications within the body and 
facilitates diseases such as atherosclerosis(Vogiatzi et al., 2009). 
 
Oxidative stress causes direct and irreversible oxidative impairment to 
macromolecules and also alters redox dependent signalling process (Drummond et 
al., 2011). A wide range of environmental factors such as ultraviolet stress, pathogen 
invasion, herbicide action and oxygen shortage induce OS. In normal healthy 
cells,free radicals are produced in anorganized manner and acts as important 
regulators of signalling molecules that are central to cell division, inflammation, 
immune function, autophagy and stress response. In contrast, uncontrolled 
production of these reactive oxidants results in OS leading to impairment of cellular 
functions and, as stated, contributes to the development of diseases including 
atherosclerosis. This may be mediated through various radical species discussed 
below. 
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1.2.1 Reactive radical species 
Reactive oxygen and nitrogen species (ROS, RNS) are continuouslyproducedwithin 
the body from internal metabolism and external exposure. Oxidative stress causes 
the formation of ROS and RNS that are oxygen and nitrogen derived small 
molecules and include radical species such as superoxide anion (O2
-), hydroxyl 
radical (OH-), and peroxynitrite (ONOO-). These free radicals are highly unstable 
because of their distribution of electrons based on their atomic or molecular structure 
(Buttery et al., 1996). As a result, they try to become stable by pairing with other 
molecules and hence are highly reactive. They can also react with other free radicals 
or take a hydrogen atom from other molecules to achieve a stable state. The levels 
of these free radicals and the ability of the antioxidant defence system to neutralise 
these species governs the consequences of OS.  
 
In most of the conditions where ROS is produced, the body’s anti-oxidant system is 
generally able to counteract their effects by inactivating the various ROS produced 
and in doing so protect against the deleterious effects of these free radicals. 
However the antioxidant defence is not always sufficient to neutralise ROSand 
maintain a balance. Thus, excessive ROS generation becomes pathological when 
their release persists long-term. In atherosclerosis, ROS may contribute to the 
pathogenesis of the disease through alteration of LDL, reducing the bioavailability of 
NO and increasing the leukocyte recruitment within the arterial wall. 
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1.2.2 Mechanisms for ROS generation in vascular cells 
Reactive oxygen species are produced from various sources in several 
compartments within the cell during normal cell regulation or as a consequence 
when exposed to pathologic or toxic insults. The different compartments within the 
cell that produce ROS are cell membrane, mitochondria, peroxisomes and 
endoplasmic reticulum. The normal source of ROS in humans is during oxidative 
phosphorylation in the mitochondria through the electron transport chain. Reactive 
oxygen species (ROS) production is neverthelessamplified when electron transport 
in the respiratory chain (RC) is impairedbut the impairment may be buffered to a 
certain extent without definite ROS formation in mitochondria(Forstermann, 2010). 
The other sources of ROS formation are mediated by enzymes such as nicotinamide 
adenine dinucleotide phosphate (NADPH) oxidase, nitric oxide synthase (NOS) and 
xanthine oxidaseas illustrated in Figure 2(Magenta et al., 2014).The NADPH oxidase 
is considered as the major source of free radicals and it mainly accelerates the 
production of O2
-. 
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Figure 1.2 Sources of reactive oxygen species (ROS) and consequences on 
endothelial function 
The various enzymatic systemslisted above generate ROS from molecular oxygen 
(O2). A single electron reduction of O2 leads to the formation of superoxide (O2
-) 
while a two-electron reduction leads to the formation of hydrogen peroxide (H2O2). 
Further, these ROS react with lipids and form active lipid radicals (Kyaw et al., 2004) 
and may cause endothelial dysfunction. One consequence of this is altered NO 
bioavailability due to inactivation by superoxide anion (O2
-) forming peroxynitrite 
(ONOO-) leading to endothelial dysfunction, vasoconstriction, platelet aggregation, 
and apoptosis (Cai & Harrison, 2000). 
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1.2.2.1 Nicotinamide adenine dinucleotide phosphate (NADPH) oxidase family 
The NADPH oxidase family consists of different enzymes such as NOX1, NOX2, 
NOX3, NOX4 and NOX5. These enzymes exhibit differences in their activity and 
localisation. NOX1 is highly expressed in vascular smooth muscle cells whereas 
NOX2 is present in neutrophils. NOX3 is highly expressed in vestibular system and 
produces low levels of superoxide (Bedard and Krause, 2007). NOX4 is generally 
expressed in all cardiovascular cell types and NOX5 is predominantly found only in 
humans. All these enzymes play an important role in the pathophysiology of several 
cardiovascular diseases as they are a major source of ROS and modulate key redox 
sensitive signalling pathways that regulate growth, proliferation, migration and 
differentiation.Their expression in macrophages is believed to dictate acritical role in 
atherogenesis (Guzik et al., 2000) and oxidized LDL itself stimulates NADPH 
oxidase and facilitates the production of O2
-, which inactivates NO (Bae et al., 
2009).NOX enzymes mediate diverse functions through redox signalling. Vascular 
NOX generate ROS which is useful in regulating blood pressure and regular 
cardiovascular health. However the excessive ROS generated will reduce the bio-
availability of NO, which then affects the blood pressure as NO regulates the flow of 
blood (Panday et al., 2015).The p22phox-dependent NOX2 is involved in the 
activation of nuclear factor kappa B (NF-κB) and inducible nitric oxide synthase 
(iNOS) through the proliferationand differentiation of smooth muscle cells (Piao et al., 
2005). NOX2 is also known to involve in the angiotensin II signaling and thus play a 
role in normal functioning of central nervous system. Out of different sources of ROS 
generation, NOX generated O2
- has been associated with atherosclerosis. It causes 
the production of cell adhesion molecules in the vascular endothelium and thus 
contributes in atherogenesis (Ushio-Fukai et al., 2002). 
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1.2.2.2 Xanthine Oxidase 
During the metabolism of purine, involves the molybdoenzyme, xanthine 
oxidoreductase that catalyses of oxidation of hypoxanthine and xanthine. Xanthine 
oxidoreductase is present in two inter-convertible forms, either as xanthine 
dehydrogenase or xanthine oxidase. Xanthine dehydrogenase involves the reduction 
of NAD+, whereas xanthine oxidase leads to the production of both O2
− and H2O2 in 
the presence of molecular oxygen (Hajjar & Leopold, 2006). Interestingly,xanthine 
oxidase appears to be regulated by interferon-, which enhances the activity of the 
enzyme in endothelial cells, strongly implicating a role for inflammation associated 
with cytokines in atherosclerosis(Dupont et al., 1992).The dysregulation of the 
enzyme results in impaired vascular function and cardiovascular diseases. Also it 
inhibits the NO synthase thus reducing the levels of NO.  Xanthine oxidase induced 
oxidative stress in the endothelium triggers the pathogenesis of endothelial 
dysfunction thus contributing to atherosclerosis. An increase in the xanthine oxido-
reductase activity is associated with infarction. Also NADPH and xanthine oxidase 
are known to be interrelated as one activates the other (Battelli et al., 2014). 
 
1.2.2.3 Mitochondrial generation of reactive oxygen species (ROS) 
Mitochondria are the most important source of ROS formation. The damage to the 
mitochondria in various pathologies is associated with ROS production within the 
mitochondria (Murphy, 2009). Theyprovide energy to the cell by generating 
adenosine triphosphate (ATP) through oxidative phosphorylation. This occurs when 
electrons are transmitted from NADH to molecular oxygen (Murphy, 2009) through a 
complex of electron transport carriers that include complex I (NADH-ubiquinone 
oxidoreductase), complex II (succinate-ubiquinone oxidoreductase), complex III 
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(ubiquinol-cytochrome c reductase), and complex IV (cytochrome c oxidase). More 
than 98% of electrons are coupled to form ATP whereas the rest leaks out to form 
O2
−. However mitochondria contain mitochondrial superoxide dismutase (MnSOD), 
which neutralises O2
−. Under pathological conditions the electron transport chain is 
uncoupled leading to disruption of MnSOD thereby resulting in increased 
O2
−production (Sena et al., 2012). 
 
1.2.2.4 Uncoupling of Nitric Oxide Synthases 
Nitric oxide synthase derived NO is a potent inhibitor of platelet aggregation and 
adhesion. It is the most anti-atherogenic defence principle in the vasculature. 
However NOS can generate O2
-instead of NO under pathological conditions. The 
enzymes transfer electrons from the heme group to the substrate L-arginine to form 
L-citrulline and NO. 5, 6, 7, 8-tetrahydrobiopterin (BH4) is used as a cofactor in this 
development.However, decrease in the availability of either BH4 or L-arginine may 
uncouple the enzymes resulting in the generation ofO2
-instead of NO (Madamanchi 
et al., 2005; Roe and Ren, 2012). The O2
-generated may alter the activity of NOS 
and react with NO to form ONOO- which has the ability to oxidize BH4 to 
BH3resulting in a decrease in BH4and hence uncoupling of NOS. Importantly, NOS 
uncoupling is also common not only in the manifested atherosclerotic state but also 
in other conditions considered risk factors for atherosclerosis. In this regards, 
uncoupled eNOS hasbeen seen in patients with endothelial dysfunction that has 
resulted from conditions such as diabetes mellitus, hypercholesterolemia or essential 
hypertension (Moens et al., 2008). These consequences reflect the importance of 
NO under normal physiological conditions, which may be compromised in disease 
states. 
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1.3 Antioxidants 
Under normal physiological conditions, cells are capable of neutralizing the reactive 
oxygen species produced with the help of antioxidants. Endogenous cellular 
antioxidant defences are primarily enzymatic that include superoxide dismutase, 
catalase and glutathione peroxidase. Superoxide dismutase is present locally in the 
cytosol and mitochondria and helps in catalysing the reduction of superoxide anion 
to H2O2 and water. Glutathione peroxidases are located in the cytosol and 
mitochondria and helps in eradicating the majority of H2O2whereas catalase, located 
in peroxisomes, is responsible for neutralizing high levels of H2O2. Non-enzymatic 
antioxidants such as vitamin E, vitamin C, -carotene, coenzyme Q and glutathione 
act by quenching reactive oxygen species. When the redox balance is altered 
towards cellular oxidants, oxidative injury to lipids and proteins occur and results in 
reduced cell viability and modification of cellular function (Lu et al., 2010). The 
intracellular redox state is assessed by the relative amounts of oxidized and reduced 
form of each redox pair. Reactive oxygen species therefore are considered as 
important parameter in evaluating the redox state of the cell and establish a 
mechanism whereby it modifies the protein conformation and function and regulation 
of signal transduction.  
 
The redox systems normally found within the cells comprise nicotinamide adenine 
dinucleotide phosphate, thioredoxin, glutaredoxin, and glutathione. Amongst these, 
glutathione serves as a principalantioxidant to maintain overall cellular redox balance 
because the cellular glutathione concentration is 500 to 1000-fold higher than the 
other redox regulating proteins. Whenever there is adiscrepancy in the ratio of 
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reduced to oxidized glutathione, it directly reflects the imbalance in intracellular redox 
state (shih et al., 2007). The importance of glutathione is not only based on its 
abundance but also its ability to counteract H2O2, lipid hydroperoxides mainly as a 
co-factor of enzymes such as glutathione peroxidase or glutathione-S-transferase 
(GST). Various pathologies have been associated with decreases in the levels of 
glutathione.  
 
In mammalian cells, glutathione is the most abundant low molecular weight thiol 
present in both the reduced (GSH) and oxidized (GSSG) forms. The GSH is 10 to 
100 fold greater than the GSSG. An upsurge in the levels of intracellular GSSG can 
be a result of the breakdown of H2O2by glutathione peroxidase. As the 
concentrations of GSSG in the cell are usually minimal,even minor oxidation of GSH 
to GSSG can affect substantial elevated levels of intercellular GSSG. The NADPH-
dependent glutathione reductase as well as thioredoxin/glutaredoxin system are 
capable of reducing the oxidized form of glutathione to GSH. Antioxidant enzymes 
such as GSH peroxidase, using GSH as a cofactor, neutralize peroxides including 
membrane lipids peroxides formed as a result of oxidative insult. Also GSH 
peroxidase in the presence of GSH can protect the biological molecules, proteins 
from free radical burst (Mezzetti et al., 1990). 
 
1.3.1 Superoxide Dismutase (SOD) 
Another important antioxidant enzyme is superoxide dismutase (SOD), whichis 
present in all oxygen-metabolizing cells (Gregory et al., 1974)andcatalyzes the 
destruction of oxygen free radical or superoxide anion. This enzyme therefore plays 
a critical role in reducing OS and its consequences in atherosclerosis and other life-
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threatening diseases.The reaction involves the dismutation of superoxide into 
oxygen and hydrogen peroxide. It acts as the first line of defense and neutralizes the 
superoxide anions through successive oxidative and reductive cycles of transition 
metal ions at its active site. 
 
2O2
- + 2H+  O2 + H2O2 
 
The critical mechanism to prevent the endothelial dysfunction caused by O2
- is the 
activity of SOD in the vessel wall. The SOD regulates the bioactivity of NO as O2
-
reacts with NO reducing its bioavailability. Therefore it acts as a balance between 
the O2
-and NO and thus maintaining its bioavailability. The important SOD is the 
extracellular SOD which protects the endothelium derived NO because of its 
location. Another important SOD is the mitochondrial SOD which neutralizes the 
generation of O2
-within the mitochondria during electron transport (Fukai et al., 
2002). 
1.3.2 Catalase 
Catalase is another major antioxidant enzyme and is present in all living organisms. 
It is encoded by a single gene and is found pre-dominantly in the liver, kidneys and 
erythrocytes. It is mainly located in the peroxisomes within the cell.It catalyzes the 
decomposition of H2O2 to water and oxygen thus protecting the cell from oxidative 
damage. The activity of catalase is very high and rapid as it is effective even at low 
concentrations. In this regard, one molecule of enzyme can convert millions of 
H2O2molecules to water and oxygen each second and is therefore very effective in 
converting H2O2 to less harmful products, thus preventing deleterious effects to 
biological systems.  
SOD 
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     2H2O2 O2 + 2H2O 
 
The overexpression of catalase was shown to inhibit ox-LDL in human aortic 
endothelial cells as H2O2 was known to involve in the production of ox-LDL (Yang et 
al., 2004). 
 
1.3.3 Heme oxygenase-1 (HO-1) 
Heme oxygenase-1 (HO-1) is anenzyme produced under stress and involved in 
catalyzing the degradation of heme to biliverdin, simultaneously releasing iron and 
carbon monoxide (CO). Heme oxygenase-1 acts as anantioxidant protection system 
within the cell during oxidative insult through the antioxidant actions of biliverdin and 
its metabolite, bilirubin, and anti-inflammatory action of CO. It plays a vital role in 
cellular antioxidant defense and, particularly, in vascular protection (Abraham & 
Kappas, 2008). 
  
Heme oxygenase was first extracted from rat liver and pig and bovine spleen and 
was found to have a molecular mass of 32KDa. The two isoenzymes of HO 
werereferred to as HO-1 and the second HO-2. Heme oxygenase-2 having a 
molecular mass of 34KDa is constitutively expressed whereas HO-1 can be 
inducedusing various pharmacological agents and under circumstancessuch as heat 
shock and cellular stress (Cruse & Maines, 1988).In whole animal tissues, when 
treated with its natural substrate heme as well as various metals, xenobiotics, 
endocrine factors and synthetic metalloporphyrins, the activity of HO-1 is elevated. 
Hence it might be possible HO-1 induction is the vital process that occurs following 
Catalase 
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some acute reactions and cellular protection after injury. Heme oxygenase-1 
facilitates the elimination of potentially toxic pro-oxidant molecule heme and 
generates metabolites with antioxidant properties such as CO, bilirubin and 
biliverdin. Thus, CO and bilirubin are important for the protection caused by HO-1(da 
silva et al., 2001). 
 
Figure 3 shows the metabolism of heme to biliverdin and then to bilirubin, which 
regulates the cellular redox. Bilirubin inhibits NADPH oxidase and Protein-Kinase C 
(PKC) activity that mediates angiotensin II induced vascular injury. Bilirubin is also 
linked to OS reduction in experimental model of diabetes by raising the bioavailability 
of NO essential for endothelial cell integrity.  
 
The possible mechanism by which HO-1 mitigates the diabetes facilitatedfree radical 
production and uncoupling of eNOS might be through the inhibition of NADPH and 
PKC by bilirubin. Glucose increasesthe levels of O2
-, which therefore interacts with 
NO leading to the vascular accumulation of ONOO-. Peroxynitrite further inactivates 
the NOS cofactor BH4 to dihydrobiopterin. As a result of this inactivation, NOS 
enzyme is uncoupled accelerating the production of O2
- over NO (Milstien & Katusic, 
1999). 
 
Also bilirubin through its anti-inflammatory and anti-oxidative properties can increase 
tolerance to islet allograft (Wang et al., 2007;Lee et al., 2007). These properties, 
along with its inhibition of proliferation of smooth muscle cells (Ollinger et al., 2005), 
mightconstitute the underlying mechanism for its positive effect in the treatment of 
atherosclerosis. Indeed, atherosclerosis progression was reduced in patients with 
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high normal levels of bilirubin when compared with that in individuals with low normal 
levels (Ollinger et al., 2007). 
 
 
 
 
Figure 1.3 Metabolism of Heme and its properties 
 
1.3.4 Nuclear factor erythroid 2-related factor-2 (Nrf-2) 
The redox sensitive transcription factor nuclear erythroid 2-related factor 2 (Nrf-2) 
plays a crucial role in the cellular defense against OS. Nrf-2 is sequestered in the 
cytosol along with Kelch-like ECH associated protein 1 (Keap 1), a cytoskeletal 
protein that anchors and represses its transcriptional activity (Alfieri et al., 2011). 
Keap1 is sensitive to oxidative and electrophilic stress and promotes rapid 
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degradation of Nrf2. Electrophilic agents or ROS interacts with Nrf2-Keap1 complex 
and dissociates the complex thus enabling nuclear translocation of Nrf-2. The 
dissociation of Nrf2-Keap1 complex may be attributed to the alterations in the 
structure of Keap1 and phosphorylation of serine/threonine residues in Nrf2. The 
main mechanism for the molecular basis of Nrf2 activation is the oxidation of redox-
sensitive cysteines within Keap1 (Tong et al., 2007). The antioxidant effects of Nrf2 
through the induction of phase II defense enzymes is regulated by the antioxidant 
response elements (ARE) in the promoter region of target genes. Nrf2 interacts with 
ARE and regulates the expression of detoxifying enzymes such as glutathione 
synthase transferase (GST), HO-1, and NQO1 (Mann et al., 2009). It serves as an 
important transcription factor in the cytoprotection of tissues against electrophiles 
and ROS. When the blood flow turns to oscillatory from laminar, shear stress is 
induced in the vascular wall leading to NO inhibition and superoxide production. This 
promotes the pathogenesis of atherosclerosis. During this process Nrf2 is 
suppressed and thereby stimulates proatherogenic environment contrary to its anti-
atherogenic effects when the blood flow is laminar (Howden, 2013).Nrf2 is 
ubiquitously expressed and modulates microglial dynamics in the brain and regulates 
the expression of inflammatory markers and antioxidant enzymes. It also plays a 
major role in neurodegenerative disorders such as Parkinson’s, Alzheimer’s and 
Huntington’s disease (Alfieri et al., 2011). 
 
These antioxidant systems, although effective under normal physiology, are often 
overwhelmed in chronic disease states including atherosclerosis. Under these 
conditions, it is likely that other processes other than sequestration of free radicals 
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may prove beneficial. In this regard, NO is emerging as a cardio protectivemolecule 
within the vessel wall.  
 
 
Figure 1.4 Dissociation of Nrf-2 and its function 
(Taken from Kobhayashi et al., 2013) 
 
1.4Nitric Oxide 
Nitric oxide is a ubiquitous molecule naturally found in a range of cell types and 
organ systems. It is an important signalling molecule, which regulates various 
physiological and cellular processes in the cells. It was initially termed “Endothelium 
Derived Relaxation Factor” (EDRF) because of its effect on blood vessel relaxation 
and vascular tone regulation(Furchgott & Zawadzki, 1980; Chen & Popel, 2009). It 
has various roles in biological processes including neurotransmission, apoptosis, 
immune defence and cell motility. Nitric oxide is akeyregulator of basal vascular 
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tone, averts platelet activationas well as cellular proliferation and migration. Nitric 
oxide also regulates myocardial contractility as well as vascular tone, whichhave 
already been mentioned.It is a highly reactive molecule and short lived with a half-life 
of 3-5 seconds. It is produced by a group of enzymes called NOS of which there are 
three types: endothelial NOS (eNOS), inducible NOS (iNOS) and neuronal NOS 
(nNOS) (Viteceket al., 2012). The NOS enzymes convert arginine to citrulline, 
producing NO in the process. They utilize reduced nicotinamide-adenine-
dinucleotide phosphate (NADPH), flavin adenine dinucleotide (FAD), flavin 
mononucleotide (FMN), and 5, 6, 7, 8-tetrahydrobiopterin (BH4)as co-factors (as 
illustrated in the Figure 4). When there is an increase in intracellular calcium levels, 
eNOS and nNOS are activated and synthesize NO. The iNOS enzyme is 
independent of calcium and therefore unaffected by a change in intracellular calcium 
levels (Ding & Vaziri, 1998). 
 
 
 
Figure 1.5 Synthesis of Nitric Oxide (NO) by the NOS enzyme(Taken from 
Gorren and Mayer, 1997). 
 
 21 
Nitric oxide released from L-arginine diffuses to smooth muscle cells where they 
stimulate soluble guanylate cyclase thereby causing enhanced synthesis of cyclic 
GMP from guanosine triphosphate. The surge in cyclic GMP in smooth muscle cells 
results in their relaxation (Garcia & Stein, 2006).Nitric oxide also has many 
beneficial effects, which accounts for various physiological functions. These effects 
are seen at low physiological concentrations where NO exerts several protective 
functions in the cardiovascular system, including the regulation of cardiac 
contractility, inhibition of smooth muscle cell proliferation, inhibition of platelet 
aggregation, suppression of monocyte adhesion to the endothelium and inhibition 
of expression of vascular cell adhesion molecule 1 (VCAM-1) and inactivation of 
nuclear factor kappa B (NF-kB), which all play a prominent role in atherosclerosis. 
Thus, reduced bioavailability of NO has therefore been implicated in the 
pathogenesis of atherosclerosis(Prasad et al., 1999). In contrast, excess amounts 
of NO may be detrimental and in the presence of O2 or O2
- forms ONOO-which, as 
already mentioned,is highly reactive and exerts a multitude of deleterious effects 
including apoptosis and pathogenesis of myocardial infarction, diabetes, chronic 
inflammatory diseases etc.In this regard, NO derived from iNOS is considered 
pathological and has until recently been relatedwith the pathogenesis of diseases 
such as atherosclerosis associated with OS which is discussed further below (See 
section 1.4.4). 
 
1.4.1 Endothelial Nitric Oxide Synthase (eNOS) 
Endothelial nitric oxide synthase or NOS3 is the predominant isoform present in the 
vasculature. It is mostly expressed in endothelial cells. It is constitutively expressed 
and activated by G-protein coupled cell surface receptors or by shear stress and 
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stretch. It requires increases in levels of intracellular calcium that can be induced 
following receptor activation. This in turn increases the activation of calmodulin and 
hence its binding to and activation of eNOS. The activity of eNOS could be 
regulated by a range of co-factors and by its intracellular localization as it facilitates 
optimal coupling of extracellular stimulation of NO  (Frutos et al., 1999). It plays a 
crucial role in the regulation of vascular tone and preserving vascular integrity.  
Under physiological conditions eNOS may generate low levels of NO, which may 
regulate the physiological processes already identified above, and include not only 
vascular tone but also platelet aggregation andcell migration and proliferation. 
 
1.4.2 Neuronal Nitric Oxide Synthase (nNOS) 
Neuronal nitric oxide synthase or NOS1 was one of the first isoforms to be purified 
and cloned. It is mainly expressed in neuronal tissues. As with eNOS, its activity is 
regulated by calcium and calmodulin and has been implicated as an important 
enzyme for synaptic signalling events. The NOS1 enzyme has been implicated in 
vital physiological functions such as learning and memory (Zhou & Zhu,2009). Its 
inhibition in the medulla and hypothalamus can lead to systemic hypertension 
(Forstermann & Sessa, 2012). 
 
1.4.3 Inducible Nitric Oxide Synthase (iNOS) 
Inducible nitric oxide synthase or NOS2 is not normally expressed in cells but can 
be transcriptionally stimulated by bacterial lipopolysaccharides and cytokines 
(Figure 5). Typically iNOS is induced in response to cellular stress and produces 
100-1000 fold more NO than eNOS and nNOS. Once expressed the enzyme is 
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constantly active and is not affected by intracellular calcium fluxes. It produces 
copious amounts of NO for comparatively long periods of time (Leifeld et al., 2002).  
 
 
 
 
 
 
Figure 1.6 Schematic representation of iNOS gene expression and 
function(Taken from Faraci and Heistad, 1998) 
 
The role of iNOS is complex and controversial and may mediate different aspects 
of cardiovascular pathologies. The enzyme was initially identified and characterized 
in macrophages; but it is now expressed in several cell types including endothelial 
cells, fibroblasts, vascular smooth muscle cells and cardiac myocytes. The iNOS 
acts as a catalyst and its action is controlled through the availability of calmodulin, 
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L-arginine and the co-factors, NADPH and tetrahydrobiopterin (as shown in figure 
5). Its expression and function has been implicated in a multitude of pathological 
conditions. 
 
1.4.4 Pathology of the inducible nitric oxide synthase and its implications 
In contrast to constitutive NO production, excess production of NO by iNOS may be 
pathologically relevant in several disease states including the pathogenesis of 
atherosclerosis. This is supported by the fact that its expression can be induced by 
inflammatory cytokines associated with the disease state (Channon et al., 2000). 
The iNOS induced overproduction of NO has also been put forward as a major 
mechanism by which cytokines exert cardiac contractile dysfunction and initiate 
cardiovascular disease.In a rabbit infarction model, treatment with specific NOS2 
inhibitor greatly improved ventricular function and also improved myocardial blood 
flow indicating adverse tissue damaging effects of iNOS derived NO production. 
Furthermore, after cardiac transplantation, iNOS expression correlated with 
contractile dysfunction in myocytes and vascular smooth muscle cells. Increased 
production of NO by iNOS may also result in vasodilation during endotoxin and 
cytokine induced shock (Kiang, 2004); and may similarly contribute to various other 
diseases such as rheumatoid arthritis (RA; Jarvinen et al., 2003), multiple sclerosis 
(MS; Hill et al., 2004), Alzheimer’s disease (Abd-El-Aleem et al., 2008) and 
Parkinson’s disease (Kavya et al., 2006). In the synovial fluid of RA, NO levels 
were detected at 6 to 35 fold higher than normal. In the demyelinating lesions of 
MS, staining of iNOS and nitrotyrosine, a product formed during nitrosative stress, 
was also detected. When these cells were isolated and cultured invitro, a high 
output of nitric oxide was seen. The expression of iNOS has also been observed in 
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chronic inflammatory ailments of the airways, the vessels, the bowels, the kidney, 
the heart and the skin(Kroncke et al., 1998).  
 
During chronic inflammatory conditions, there is increase in the expression of iNOS 
thus accumulating high levels of NO that can cause DNA damage through its 
reactive intermediates, which are mutagenic. Recent studies also associate NO as 
being a key signaling molecule that promotes tumorigenesis, with amplified 
expression of iNOS involved in tumors of the colon, lung, oropharynx, reproductive 
organs, breast, and central nervous system (CNS). Moreover, uncontrolled iNOS 
activation in resident macrophages and smooth muscle cells results in excess 
production of ONOO-, which is pro-atherogenic and pro-thrombogenic and a source 
of constant nitrosative stress, which is detected abundantly in atherosclerotic 
lesions in the form of nitrotyrosine. Prolonged stress over a period of time results in 
atherogenesis especially in those individuals with poor anti-oxidant defence 
mechanisms. Peroxynitrite could also induce the expression of metalloproteinase in 
the vascular interstitium that induce atherosclerotic plaque rupture and myocardial 
infarction (Baker et al., 1999). Moreover, iNOS co-localizes with poly-(ADP-ribose)-
polymerase-1 within vascular smooth muscle cells of atherosclerotic human aorta. 
Poly-(ADP-ribose)-polymerase-1 localizes within the nuclei of smooth muscle cells 
in the lesions. Hence it causes change in the morphology of mitochondria resulting 
in considerable damage leading to the deterioration of the condition. This shows 
the significant role of iNOS and poly-(ADP-ribose)-polymerase-1 in atherosclerotic 
lesions of humans (Perrotta et al., 2011). 
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In contrast to the strong argument above for a pro-atherogenic role for iNOS, recent 
studies have indicated that this isoform may in fact be cardio protective. For 
instance, it has been reported that iNOS-induced NO has anti-atherogenic effects 
as it improves endothelial dysfunction, maintains plaque stability and prevents 
platelet aggregation (Lirk et al., 2002). Additionally, iNOS-induced NO may also 
prevent cell-mediated oxidative modification of LDL (Buttery et al., 1996) and in 
vivo, attenuate the extent of the atherosclerotic lesion induced by immune injury, as 
well as protect against OS-induced apoptosis (Rikitake et al., 1998). Moreover, 
overexpression of this enzyme is reported to reduce infarct size (Arnaud et al., 
2001). 
 
Inducible nitric oxide synthase derived NO plays a crucial role as a cardio 
protective molecule in ischemia/reperfusion injury. Inhibition of iNOS uncoupling, 
which is instigated by OS, results in reduced infarct size and improved functioning 
of the left ventricle (Okazaki et al., 2011; Ma et al., 2014). This suggests that 
contrary to its reported deleterious actions in atherosclerosis, iNOS may in fact 
protect against the disease developmentand reduce its subsequent adverse 
effects. This would however be contradictory to the reported pro-atherogenic 
effects of iNOS mediated via the formation of ONOO- in the atherosclerotic lesions 
(Modlinger et al., 2004). As a hypothesis, it is therefore potentially possible that OS 
may play a major role in shielding the protective functions of iNOS mediated NO 
release and instigates damaging effects leading to progression of the disease. In 
this context, iNOS induced NO may alternatively be cardioprotective (Goetzenich et 
al., 2014) and beneficial rather than deleterious in humans. 
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1.5 Statins and their role in atherosclerosis 
Statins are one of the most extensively prescribed drugs in the United Kingdom and 
are consumed by almost eight million Britons. Theyare a class of drugs that 
areresponsible for lowering the levels of cholesterol produced in the liver, exerting 
this effect by inhibiting the activity of the rate limiting enzyme 3-hydroxy-3-methyl 
glutaryl co-enzyme A reductase (HMG CoA reductase) and are therefore also 
referred to as HMG-CoA reductase inhibitors (Wierzbicki et al., 2003). The HMG-
CoA reductase catalyzes the reduction of 3-hydroxy-3-methyl glutaryl co-enzyme A 
(HMG-CoA) to mevalonate, which is the rate-limiting step in hepatic cholesterol 
biosynthesis thereby inhibiting de novo cholesterol synthesis. In addition, they 
increase the expression of LDL receptors, which are involved in the uptake of LDL. 
They also cause a reduction in triglyceride levels and a minor increase in high-
density lipoproteins (HDL) cholesterol (Nichollset al., 2014).  
 
In terms of the consequences of their action, statins prevent advancement of 
atherogenesis by reducing plaque progression. They also act by inhibiting the 
oxidation of LDL through preservation of the activity of anti-oxidant system and may 
lower inflammation along the walls of the arteries. Statins also constrain 
isoprenylation of key proteins involved in oxidant/anti-oxidant-generating pathway 
thus producing anti-oxidant effects (Shishehboret al., 2003). In this regard,statin 
therapy has been shown to suppress O2
-formation and thus enhanced NO 
generation through inhibition of isoprenylation of Rac and Rho. Rac is present within 
the NAD(P)H oxidase complex of both leukocytes and vascular cells. Statins 
promote the inhibition of Rac isoprenylation, thereby inhibiting its translocation to 
membranes and hence suppression in O2
-formation in cultured cells.  
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Rho is a small GTPase that regulates signaling within the cell. Studies reveal that 
inhibition ofRho isoprenylation in endothelial cells resulted in greaterNO production, 
presumably due to enhanced stability of eNOS mRNA half-life (Rikitake & Liao, 
2005).Furthermore, they weakenthe progression of atherosclerosisby retarding the 
vascular smooth muscle cell proliferation and migration and hence inhibit plaque 
development and new lesion formation (Stancu & Sima, 2001; Mason,2003). 
 
The non-lipid effects of statins include increase in NO bioavailability through 
preventing its oxidative inactivation by O2
-radicals and by up-regulation, activation 
and stabilization of eNOS(Kolyada et al., 2001; Ma & Ma, 2014).Statins also exert 
their non-lipid effects through inhibition of OS, anti-thrombotic actions, regulation of 
angiogenesis, anti-inflammatory effects, decrease in secretion of metalloproteinase 
and attenuation of endothelial dysfunction (Lahera et al., 2007; Agouridis et al., 
2015). These so called pleiotropic effects are independent of the inhibition of 
intracellular cholesterol biosynthesis and are secondary to the inhibition of the 
synthesis of isoprenoid intermediates of mevalonate pathway, such as 
farnesylpyrophosphate (FPP) and geranylgeranylpyrophosphate (GGPP). These 
non-lipid actions contribute to the clinical benefits of statins in cardiovascular 
diseases(Szyguta-Jurkiewicz et al., 2014; Agouridis et al., 2015). 
Statins exert its effects through various pathways and one of those appears to be the 
regulation of the activity of the enzyme cholesteryl ester transfer protein (CETP), 
which transfers cholesteryl ester to very-low-densitylipoprotein (VLDL) and LDL.Most 
of the studies emphasize that simvastatin and pravastatin inhibit the activity of 
plasma CETP in normo-lipidemic individuals and also in patients enduring different 
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kinds of hyperlipoproteinemia. The mechanisms of these effects are unidentified but 
might facilitate effects outside of lipid metabolism (Kuivenhoven et al., 1998). 
 
Recent studies reveal another novel lipid-independent pleiotropic effect of statins, 
which is distinct to their inhibitory potential on HMG-CoA reductase. It might exert an 
anti-inflammatory effect by binding to a specific site of the lymphocyte function 
associated antigen-1 (LFA-1) on leukocytes. This selective binding prevented any 
adhesion to LFA-1. These additional properties of statins suggest considerable 
cardiovascular beneficial properties of these drugs in both normal and 
hypercholesteromic individuals that go beyond their cholesterol lowering actions. 
However there is a need for more studies to appreciate the clinical relevance of the 
non-lipid lowering properties of statins in humans (Weltz-Schmidt et al., 2001). 
 
Oxidised LDL has high affinity and bind to extracellular matrix which promotes 
inflammation as well as chemo taxis of monocytes. The latter once trapped in the 
intima form macrophages, which engulf oxLDL to form foam cells that are part of the 
atherosclerotic lesions, and also activates NF-B (Nakata et al., 2007). Statins 
prevent the oxidation of LDL and in so doing reduce the formation of oxLDL and 
decrease O2
-anion production thereby producing beneficial effects in atherosclerosis. 
Statins also decrease the levels of oxLDL either by decreasingLDL levels or by 
increasing HDL production. NADPH oxidases are the important source ofO2
-. 
Theyinhibit oxLDL-induced NADPH oxidase expression and as a result suppress O2
-
anion production (Wong et al., 2006). In a previous project in our laboratory, statins 
were found to reverse the suppression of iNOS expression and NO production 
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caused by pro-oxidants in LPS and IFN- activated smooth muscle cells 
(unpublished observations). Interestingly, this effects which may be beneficial in 
controlling the development and/or progression of atherosclerosis was selective to 
certain statins (eg atorvastatin) and not others (eg pravastatin). Thus, although all 
these effects make statins an important class of drugs for treating coronary artery 
disease, there is yet a lot more required in order to understand the multitude of 
effects they exert. In particular it is important to understand how these drugs regulate 
iNOS expression and what the relevance of this is in OS associated with 
cardiovascular diseases such as atherosclerosis. This is being addressed in part in 
this thesis. 
 
1.6 Aims and Objectives 
The main aim of this thesis is to extend initial observations showing that iNOS 
expression and function may be regulated under conditions of OS by exploring the 
underlying mechanism through which this may be mediated. In particular, the studies 
aim to establish whether suppression of iNOS expression is dependent on the 
species of free radical generated and further identify the signalling pathway through 
which this may occur. Additionally, parallel studies will examine the effects of select 
statins on OS induced changes in iNOS expression and NO production as well as 
the mechanisms that may be associated with the actions of the selected statins. 
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2.0 MATERIALS AND METHODS 
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2.1 Cell culture materials and methods 
 
2.1.1 Preparation of mediarequired for culturing of cells 
2.1.1.1 Cell culture medium: Freshly prepared complete culture medium was used 
for culturing and sub culturing of cells. Complete culture medium was prepared by 
supplementing Dulbecco’s modified Eagle’s medium (DMEM) (Fisher scientific, UK) 
with 10% Foetal bovine serum (FBS) (Fisher scientific, UK), 100 U/ml penicillin and 
100 µg/ml streptomycin (Fisher scientific, UK). DMEM contains essential nutrients 
and vitamins, FBS provides serum supplement, which promotes the growth and 
proliferation of cells in culture. 
 
2.1.1.2 Phosphate buffered saline (PBS): Sterile 1x phosphate buffered saline 
(PBS) was prepared from 10x stock solution (Invitrogen, UK) by 1 in 10 dilutions in 
autoclaved double distilled water (DDW). 
 
2.1.1.3 Trypsin: Sterile 1x trypsin was prepared from 10x stock solution (Invitrogen, 
UK) by diluting 1 in 10 in sterile 1x PBS so that the final concentration of the solution 
contains 0.05% trypsin. 
 
Once prepared, all the above solutions were stored at 40C and used within 3 months 
from the date of preparation. 
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2.1.2 Isolation and culture of rat aortic smooth muscle cells 
Rat aortic smooth muscle cells (RASMCs) were used for the experiments. Culture 
conditions for the isolation of these cells from male Sprague-Dawleyrat aorta were 
optimised. The protocol used has been developed from that described previously by 
Wileman et al., (1995). Aorta was collected in complete culture medium and taken 
into the tissue culture hood. The aorta was cleaned by washing away blood clots and 
removing connective tissue attached to the vessel before cutting open to expose the 
endothelium. A scalpel blade was used to remove the layer of endothelial cells and 
was separated into 2 pieces. Then the aorta was cut into 2mm sections and 4-5 
explants were placed in each T-25 flask endothelium face down. The flasks were 
then incubated in the upright position for 5 hours in a cell culture incubator gassed 
with 5% carbon dioxide at 37oC to allow the explants to attach to the surface of the 
plastic. Each flask was subsequently placed horizontally and a further 5ml of 
complete culture medium was added to the flask and incubated for 5 days, during 
which cells migrated from the tissues. 
 
2.1.3 Maintenance of cells in culture 
Once isolated, cells were maintained in culture in complete culture medium until 
confluent. When the cells became confluent, they were trypsinized and transferred 
into a new flask as explained in section 2.1.4. During the growth period of the cells, 
the medium in the flask was replenished every two days and the cells were used for 
experiments from passage 3 to 6. 
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2.1.4 Trypsinization of cells 
Trypsinization of cells was carried out when cells were 80-90% confluent to ensure 
they were maintained in a healthy viable state. Briefly, the medium was removed 
from the T-75 flask by aspiration and the monolayer of cells was washed 3 times with 
10ml of 1xPBS. 5ml of trypsin was then added to the cells and the flask gently 
swirled for 5 seconds. Excess trypsin was removed from the flask by aspiration 
leaving just about 0.5ml. The flask was then tapped gently on the sides until the cells 
weredetached. Complete culture medium was added to the cell suspension to 
inactivate the trypsin. This process was completed rapidly to ensure that the cells 
were not exposed to trypsin for too long as this may be toxic and may cause cell 
death. Finally the cell suspension was diluted for plating as required, 
 
2.1.5 Cryopreservation of cells 
Confluent monolayers of cells in T75 flask were washed 3 times with 10ml of 1x PBS 
and the cells trypsinised as described above. 8ml of complete culture medium was 
added to the cell suspension and transferred into a centrifuge tube, which was 
centrifuged at 1100 rpm at 40C for 5 min. The medium was discarded by aspiration 
without disturbing the pellet which was re-suspended in freezing medium containing 
48% DMEM, 40% FBS, 10% dimethyl sulfoxide (DMSO; Sigma-Aldrich, UK) and 2% 
Penicillin/Streptomycin. The cells in the freezing medium were then transferred into 
1ml cryogenic vials and were frozen at -800C for 24 hours using a Mr Frosty before 
subsequently being transferred into liquid nitrogen for long-term storage. 
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2.1.6 Cell counting and plating  
After centrifugation of cells following trypsinization, the medium was discarded by 
aspiration and the pellet re-suspended in 5ml of complete culture medium. 20µl of 
cell suspension was added to 20µl of 0.4% tryphan blue (Fisher scientific, UK)in an 
eppendorf tube. A 20µl aliquot was then loaded into the two sides of a Neuber’s 
chamber and this was placed into the counting port of a CountessTM automated cell 
counter (Invitrogen, UK). The latter determines total cell count and is also able to 
distinguish viable and non-viable cells. The amount of live cells available for plating 
was then determined as shown in the example below: 
 
Chamber A: 
Total cells counted = 2.4 x 105/ml 
Live cells = 2.1 x 105/ml 
Viability = 89% 
 
Chamber B: 
 Total cells = 3.1 x 105/ml 
Live cells = 2.5 x 105/ml 
Viability = 80% 
 
Average of live cells from chambers A and B = 2.3 x 105/ml 
 
Once counted, the volume of cell suspension required for plating was determined as 
follows:  
Required cells to be plated per well in a 6-well plate = 3.7 x 105 cells  
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Total cells required per plate: 3.7 x 105 x 6 = 22.2 x 105 cells per plate 
The amount of average live cells per ml = 2.3 x 105 
Therefore to get 22.2 x 105cells X ml of total cell suspension will be required 
Hence X = 22.2 x 105 /2.3 x 105ml = 9.65 ml 
 
Thus a volume of 9.65 ml of cell suspension was taken and suspended into a total 
volume of 18 ml and 3 ml added into each well in a 6-well tissue culture plastic.  
 
 
2.2 Experimental procedures 
2.2.1 Treatment of cells with LPS and IFN-: 
Once plated, cells were allowed to reach confluency before being activated with 
bacterial lipolysaccharide (LPS; 100 µg/ml) and interferon-gamma (IFN-; 100 U/ml) 
and incubated for 24 hours to induce iNOS expression and NO production. After 
24hrs incubation, the medium was collected and analysed for NO produced by the 
Griess assay. The cell monolayer was lysed and used inwestern blotting for iNOS 
expression. 
 
LPS (Sigma, UK) was prepared at 10mg/ml and aliquoted in 200µl amounts, which 
werestored at -200C. IFN- (Calbiochem, UK) was available at 10,000 U/ml from 
source andwas aliquoted in 50µl volumes beforestoring at -800C. 
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2.2.2 Treatment of cells with OS inducers 
Confluent monolayer of cells in a 24-well tissue culture grade plastic were washed 
twice with 1x PBS and incubated with diethyl maleate (DEM) (1µM, 2.5µM, 5µM and 
10µM), hydrogen peroxide (H2O2) (50µM, 100µM, 150µM and 300µM) or antimycin A 
(25µM, 50µM, 100µM and 150µM) for 30 minutes. The cells were subsequently 
incubated in complete culture medium alone or medium containing LPS (100 µg/ml) 
and IFN- (100 U/ml) for a further 24 hours before determining NO produced by the 
Griess assay. The cell monolayer was then lysed and used for western blotting to 
determine iNOS expression. 
 
Diethyl maleate (DEM) is a maleate ester produced as a result of formal 
condensation of both carboxy groups of maleic acid with ethanol. In organic 
synthesis, it is generally used as a dienophile for diels-alder type cycloaddition 
reaction. It prevents formation of anti-oxidant gluthathione by inhibiting glutathione 
synthase enzyme (Kaur et al., 2006). As a result there is an increase in the pro-
oxidant levels causing deleterious effects. Hydrogen peroxide by comparisonis a 
compound with an oxygen-oxygen single bond and is a colourless liquid having 
viscosity slightly higher than water. It acts as a major factor in free radical associated 
aging and has an important role as a signalling molecule in the regulation of 
numerous biological processes (Romero and Lamas, 2014). Hydrogen peroxide is 
thermodynamically unstable and readily gets converted to water and oxygen thus 
leading to the formation of OH- radical. Antimycins represent a group of secondary 
metabolites resulted from Streptomyces bacteria. Antimycin A with an empirical 
formula C28H40O9N2 prevents the oxidation of ubiquinol by binding to the Qi site of 
cytochrome c reductase during the electron transport chain of oxidative 
 38 
phosphorylation in the mitochondria. This leads to the disruption of formation of 
proton gradient through the inner membrane. As a result protons become incapable 
to stream through the ATP synthase complex resulting in inhibition of ATP synthesis. 
Instead, a large quantity of toxic free radical superoxide is formed which causes OS. 
Antimycin A has been extensively used to detect the specific sites of reactive radical 
species produced in mitochondria isolated from skeletal muscle. 
 
DEM (Sigma-aldrich, UK) was prepared in 50% ethanol at a stock concentration of 
50mM and then diluted to give 1µM, 2.5µM, 5µM and 10µM in complete culture 
medium. H2O2(Sigma-aldrich, UK) was prepared at 20mM in milli Q water and diluted 
to 50µM, 100µM, 150µM and 300µM in complete culture medium.  Antimycin A 
(Sigma-aldrich, UK) was prepared in 75% ethanol 50mM and diluted to 25µM, 50µM, 
100µM and 150µM in complete culture medium. 
 
2.2.3 Treatment of cells with OS inducers for free radical generation 
 
50-60% confluent monolayer of cells in a 12-well tissue culture grade plastic were 
washed twice with 1x PBS and incubated with diethyl maleate (DEM) (1µM, 2.5µM, 
5µM and 10µM), hydrogen peroxide (H2O2) (50µM, 100µM, 150µM and 300µM) or 
antimycin A (25µM, 50µM, 100µM and 150µM) for 1min, 5min, 15min, 30min, 1hr, 
3hr, 6hr and 24hr. Cells were then washed twice with x1 PBS to remove any traces 
of medium.   
2,7-dichlorofluorescein (Sigma-Aldrich, UK) was dissolved in DMSO at a stock 
concentration of 10mM and diluted to a working concentration of 20µM in x1 PBS. 
MitoSOX Red (Fisher Scientific, UK) was prepared at a stock concentration of 5mM 
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in 13µl of DMSO before diluting it to a final concentration of 5µM in Hank’s balanced 
salt solution (HBSS; Fisher Scientific, UK).Cells were incubated with 20µM of 2,7-
dichlorofluorescein or 5µM MitoSOX Red for 10 minutes, washed 3 times with x1 
PBS with a 5-minute interval between each wash before viewing under the confocal 
laser scanning microscope. 
 
2.2.4 Treatment of cells with OS inducers and statins 
Confluent monolayer of cells in a 24-well tissue culture grade plastic were washed 
twice with 1x PBS and incubated with atorvastatin (1µM, 3µM, 10µM and 30µM) for 
30 minutes before incubating with DEM (1-10µM), antimycin A (25-150µM) or H2O2 
(50-300μM) for a further 30 minutes. Cells were then incubated in complete culture 
medium alone or medium containing LPS (100 µg/ml) and IFN- (100 U/ml) for a 
further 24 hours before determining NO produced by the Griess assay. The cell 
monolayer was then lysed and used for western blotting to determine iNOS 
expression. 
 
Atorvastatin (Sigma-aldrich, UK) was prepared at the stock concentration of 10mM 
by dissolving in dimethyl sulfoxide (DMSO; Fisher Scientific, UK) and then diluted to 
1µM, 3µM, 10µM and 30µM in complete culture medium. 
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2.2.5 Treatment of cells with OS inducers and polyethylene glycol-superoxide 
dismutase (PEG-SOD) or polyethylene glycol-catalase (PEG-catalase) 
 
 
Polyethylene glycol-superoxide dismutase (Sigma-Aldrich, UK) was prepared at a 
concentration of 2110 U/ml in de-ionised water and diluted to 500 U/ml in complete 
culture medium. Polyethylene glycol-catalase (Sigma-Aldrich, UK) was dissolved in 
de-ionised water at a concentration of 30,000 U/ml and diluted to 500 U/ml in 
complete culture medium. 
 
Confluent monolayer of cells in a 24-well tissue culture grade plastic were washed 
twice with 1x PBS and incubated with PEG-SOD (500 U/ml) or PEG-catalase (500 
U/ml) for 30 minutes before incubating with DEM (10µM), antimycin A (100µM) or 
H2O2 (300μM) for a further 30 minutes. Cells were then incubated in complete 
culture medium alone or medium containing LPS (100 µg/ml) and IFN- (100 U/ml) 
for a further 24 hours before determining NO produced by the Griess assay. The cell 
monolayer was then lysed and used for western blotting to determine iNOS 
expression.       
 
2.2.6 Time point analysis of the effects of OS inducers 
Confluent monolayer of cells in a 24-well tissue culture grade plastic were washed 
twice with 1x PBS and activated with LPS (100 µg/ml) and IFN- (100 U/ml) prior to 
incubation with DEM (10µM) or antimycin A (100µM) at 5min, 15min, 30min, 1hr, 
3hrs, 6hrs, 12hrs, 18hrs and 24hrs post activation with LPS and IFN-NO 
production was determined by the Griess assay 24hr after incubation withLPS and 
IFN-. The cell monolayer was then lysed and used for western blotting to determine 
iNOS expression. 
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2.3 Griess assay 
The Griess assay is a spectrophotometric assay which is used to measure nitrite 
(NO2
-) levels, one of the two primary stable and non-volatile breakdown products of 
NO. As NO is unstable it breaks down to NO2
- and nitrate (NO3
-). This assay is 
established on a diazotization reaction initially described by Griess in 1879. It 
involves a chemical reaction of nitrite with 0.2% N-1-naphthylethylenediamine 
dihydrochloride (Griess reagent I; Sigma-Aldrich, UK) to form a diazonium salt, which 
then reacts with 2% sulfalinamide (Griess reagent II; Sigma-Aldrich, UK) in 5% 
phosphoric acid to form a pink azo dye as shown in figure 6. This assay revealsthe 
levels of nitrite in a diverse range of biological and experimental fluids such as 
plasma, serum, urine and tissue culture medium. 
 
 
Figure 2.1Griess reaction for the detectionof nitrite 
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Assay:Briefly, a sodium nitrite standard curve was first constructed by dissolving 
0.0345gm of sodium nitrite (Sigma-Aldrich, UK) in 5 ml of complete culture medium 
to give a 100mM stock solution. A 10µl aliquot was taken from the stock and diluted 
to 1ml with complete culture medium to give a 1mM working solution. Nitrite 
standards were then prepared as shown in the table below (Table 1). A 100µl aliquot 
of each standard was added in triplicate to separate wells in a 96-well plate. Also, 
100µl of each sample was added in triplicate to the remaining wells on the plate. The 
Griess reagent was prepared by mixing solutions I and II in a 1:1 ratio. 100µl of the 
reagent was added to both standard and sample wells and each plate was placed on 
an orbital shaker for 15 min at room temperature before reading the absorbance 
values at 540 nm. An example of a standard curve routinely obtained is shown in 
figure 7. 
Table 1: Preparation of serial dilutions of NaNO2 
 
Concentration of 
NaNO2 (mM) 
µl of 1mM NaNO2 µl of DMEM Final Concentration of 
NaNO2 (nmoles/100µl) 
0 0 1000 0 
0.01 10 990 1 
0,02 20 980 2 
0.03 30 970 3 
0.04 40 960 4 
0.05 50 950 5 
0.1 100 900 10 
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Figure 2.2A representative Nitrite standard curve 
 
Concentrations of NaNO2 ranging from 0-0.1mMwere prepared in complete culture 
medium. Each concentration was added in triplicates in a 96-well plate and 
incubated for 15 minutes with 100µl Griess I and II reagents. Absorbance values 
were taken at 540 nm on a Labsystems Multiskan Ascent micro plate reader. Data 
shown are the mean of three replicates for each concentration. 
 
Analysis: The average absorbance of the blank was subtracted from the average 
absorbance values of the samples. The subtracted value was substituted in the 
equation shown below obtained from the standard curve to determine the 
concentration of nitrite (nmoles/100µl) in the sample. 
 
 
x=(y-0.090)/0.002 where y= average absorbance-blank value  
                                         x= concentration of nitrite (nmoles/100µl) 
y = 0.090x + 0.002
R² = 0.999
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2.4 Cell lysis 
Cell lysis was carried out to extract protein from the cells so that they can be 
analysed by western blotting. Confluent monolayer of cells in 24-well plates were 
washed three times with 500µl of ice cold 1x PBS to remove traces of serum and 
culture medium. 100µl of 1x hot lysis buffer consisting of 2 mM Tris (pH 7.4; Fisher 
scientific, UK) and 1% sodium dodecyl sulphate (SDS; Sigma-Aldrich, UK) was then 
added to each well. The cells were scraped into the buffer and the lysates were 
collected into eppendorf tubes which were subsequently sonicated for 30 seconds 
interval over90 seconds. The samples were then boiled for 5 minutes at 950C and 
centrifuged for 20 minutes at 13,000rpm. The supernatant was transferred into a new 
eppendorf tubes and stored at -200C until analysed. 
 
Generation of lysates for the detection of phospho proteins:Confluent 
monolayers of cells in 24-well plates were washed three times with 500µl of ice cold 
1x PBS to remove traces of serum and culture medium. 100µl of 1x lysis buffer 
consisting of 2 mM Tris (pH 7.4), phosphatase inhibitor cocktail 2 (1:100 dilution; 
Sigma-Aldrich, UK) and 1% SDS was added to each well. The cells were scraped 
into the buffer and the lysates were collected into eppendorf tubes which were 
subsequently sonicated for 30 seconds interval over90 seconds. The samples were 
then boiled for 5 minutes at 950C and centrifuged for 20 minutes at 13,000rpm. The 
supernatant was transferred into a new eppendorf tubes and stored at -200C until 
analysed. 
2.5Determination of total cell protein using bicinchoninic acid (BCA): 
This assay is used to determine the amount of protein present in the sample. The 
first step involves the reduction of copper (Cu+2) to cuprous (Cu+1) by protein in an 
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alkaline environment resulting in a light blue complex. The second step involves the 
reaction of BCA with Cu+1 resulting in the formation of intense purple colour. Two 
molecules of BCA react with one Cu+1 ion forming a complex that is water-soluble 
(Figure 8). The absorbance was measured at 620nm. The stronger the absorbance 
the more is the amount of protein (Walker, 1994). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.3 BCA chelation with a cuprous ion 
 
Assay:For the determination of protein, 10mg of bovine serum albumin (BSA; Fisher 
scientific, UK) was weighed and dissolved in 1ml double distilled water (DDW) to 
make a solution of 10mg/ml concentration. Protein standards were prepared with the 
stock solution of different concentrations as shown in the table below (Table 2). 
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Table 2: Preparation of a protein standard curve 
 
Protein per well (µg) 10mg/ml BSA (µl) DDW (µl) Final concentration 
(µg/µl) 
0 0 1000 0 
1 20 980 0.2 
2 40 960 0.4 
3 60 940 0.6 
5 100 900 1 
10 200 800 2 
15 300 700 3 
20 400 600 4 
25 500 500 5 
 
BCA reagent B (Fisher scientific, UK)that contains 4% w/v copper (II) sulphate 
pentahydrate (CuSO4.5H2O) was mixed with BCA reagent A (Sodium carbonate, 
Sodium bicarbonate, bicinchoninic acid and Sodium tartrate in 0.1M sodium 
hydroxide; Fisher scientific, UK) in 1 in 50 dilution. A 96-well plate was set up as 
follows: 
 
Control wells: 5µl DDW + 5µl lysis buffer (x1) + 100µl BCA solution 
Standard wells: 5µl standards + 5µl lysis buffer (x1) + 100µl BCA solution 
Sample wells: 5µl DDW + 5µl lysate + 100µl BCA solution 
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The plate was incubated for 45min at room temperature on an orbital shaker and the 
absorbance was read at 620nm on a Labsystems Multiskan Ascent plate reader. 
Each standard or sample was analysed in triplicates. The average absorbance of the 
blank standard was subtracted from the average absorbance of other standard 
values. A protein standard curve was plotted using standard protein concentrations 
(µg/µl) on the x-axis and corrected absorbance values of thestandards (measured 
absorbance-blank absorbance (nm)) on the y-axis. An example standard curve 
routinely obtained is shown in Figure 9. 
 
 
Figure 2.4A representative protein standard curve 
 
Concentrations of BSA ranging from 0-30µg were prepared in DDW. Each 
concentration was added in triplicates in a 96-well plate and incubated for 1hr with 
100µl BCA reagent solution. Absorbance values were taken at 620 nm on a 
Labsystems Multiskan Ascent micro plate reader. Data shown are the mean of three 
replicates for each concentration. 
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Analysis:The average absorbance of the blank was subtracted from the average 
absorbance values of the samples. The subtracted value was substituted in the 
equation shown below obtained from the standard curve to determine the protein 
concentration (µg/µl). The protein concentration obtained was then used to 
determine the loading volume for western blot analysis. 
 
x=(y-0.090)/0.002 where y= average absorbance-blank value  
                                         x= concentration of protein (µg/µl). 
 
2.6 MTT assay 
The MTT assay is a colorimetric assay involving the breakdown of yellow water-
soluble tetrazolium salt 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide 
(MTT) to dark-blue, water-insoluble formazan crystals (as shown in figure 10). This 
reaction is catalysed by the mitochondrial enzyme succinate dehydrogenase and it 
occurs only in living cells. Hence this assay is useful in determining the viability of 
cells as the higher the absorbance the higher the proportion of live cells (Hughes et 
al., 2003). 
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                    Tetrazolium salt                                         Formazan 
 
 
Figure 2.5 Formation of water insoluble Formazan from MTT in the presence of             
Succinate dehydrogenase 
 
In the assay, confluent monolayers of cells in 96-well plates were treated with 
complete culture medium alone or with medium containing DEM (1µM, 2.5µM, 5µM, 
10µM and 25µM), H2O2 (150µM, 300µM, 500µM, 1000µM and 2000µM) or antimycin 
A (10µM, 25µM, 50µM, 100µM, 150µM) and incubated for 24hrs. The assay was 
performed 24 hrs later as explained below. 
 
Assay:5mg/ml MTT solution (Sigma-Aldrich, UK) was prepared by dissolving 0.05g 
in 10ml PBS. 2ml was taken and diluted to 20ml with complete culture medium to get 
0.5mg/ml concentration. The medium in the 96-well plate was aspirated and 200µl of 
0.5 mg/ml solution was added to each well and the plates were incubated at 370C for 
4 hours. The medium was then removed and 200µl of isopropanol was added before 
placing the plates on an orbital shaker for 15 min. Absorbance readings were taken 
at 540nm on Labsystems Multiskan Ascent plate reader. 
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2.7 Western blotting 
This technique is used to identify the protein of interest usinga selective antibody 
against the targeted protein. It involves the separation of proteins on a 
polyacrylamide gel (SDS-PAGE), which are then transferred from the gel onto a 
nitrocellulose or polyvinylidene fluoride (PVDF) membrane so that the antigens 
become accessible to the antibodies. A primary antibody is added then followed by 
secondary antibody, which detects the protein of interest. The remaining sites on the 
membrane are blocked using a milk protein to prevent non-specific binding of the 
antibody to the membrane. Primary antibody detects the specific protein of interest 
whereas the secondary antibody targets the primary antibody (Blancher & Jones, 
2001). 
 
Assay:Glass plates were first set up and checked for any leaking using water which 
was subsequently poured out and the plates were allowed to dry before pouring the 
gel solution. 
 
Resolving gel: The solution (4 gels) was prepared with 4.64ml of DDW, 2.66ml of 
30% acrylamide : bis-acrylamide(Fisher scientific, UK), 2.5ml of 1.5M Tris-HCl (pH 
8.8), 100µl of 10% SDS, 100µl of 10% ammonium per sulphate (Sigma-Aldrich, UK) 
and 6µlTEMED (Fisher scientific, UK). 3.5 ml solution was poured between the glass 
plates. A thin layer of water-saturated iso-butanol was added on top of the gel to 
remove any air bubbles and allowed the gel to set in the absence of oxygen.  
 
Stacking gel: After the resolving gel had polymerised, a stacking gel solution was 
prepared which consists of 2.44ml of DDW, 0.52ml of 30% acrylamide : bis-
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acrylamide, 1ml of 0.5M Tris-HCl (pH 6.8), 40µl of 10% SDS, 20µl of 10% 
ammonium per sulphate and 4µlTEMED. The water-saturated isobutanol was 
removed from the top of the resolving gel and the staking gel solution was poured 
between the glass plates. A comb was positioned into the latter and left in place for 
the wells to form.  
 
After the stacking gel had polymerised, the comb was removed and gels were placed 
onto a cassette and into an electrophoresis tank consisting of 1x tank buffer. A 10x 
tank buffer was prepared with 0.25M Tris, 1.92M glycine (Fisher scientific, UK) and 
1% SDS and diluted to 1x on the day of use.  
 
Sample preparation: Samples for analysis were prepared by adding 2x loading 
buffer (250μM Tris of pH 6.8, 4% SDS, 10% glycerol, 2% -mercaptaethanol (Sigma-
Aldrich, UK), 0.006% Bromophenol blue (Sigma-Aldrich, UK)) to the lysates 
generated from treated cells. Samples were boiled at 950C for 5 minutes and 
centrifuged for 20 minutes at 13,000 rpm.  
 
Gel electrophoresis: The samples were loaded into the lanes with molecular weight 
marker (Cell signalling, UK) in the first lane. The electrophoresis apparatus (Bio-Rad, 
UK) was connected to a power pack (Bio-Rad, UK) and the gels ran at 220 volts and 
20 milli amps (mA) per gel until the samples migrate to the border of the resolving 
gel. The current was then increased to 25mA per gel until the dye phase reached the 
bottom of the gel. 
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A PVDF membrane (Fisher scientific, UK) and filter paper were cut to the same 
dimensions as the gels. The PVDF membrane was soaked in pure methanol for 15 
seconds and then washed in DDW for 2 minutes to reduce the hydrophobicity of the 
membrane and enhance the adsorption of proteins that were separated by size in 
the gel. The membrane and gel were set up in a semi-dry transfer cell by placing wet 
filter paper first and the membrane followed by the gel and then additional soaked 
filter paper. Transfer buffer was added to the sandwich on the blotter and incubated 
for 5 minutes. The 1x transfer buffer was prepared from a 10x stock consists of 
48mM Tris base (pH 7.5), 39mM Glycineand 0.0375% SDS. On the day a 1x solution 
was prepared by carrying out a 1:10 dilution and adding 20% methanol (Fisher 
Scientific, UK). The transfer cell (Thermo Scientific, UK) was connected to a power 
supply and run at 25 volts for 20 minutes.  
 
Blocking of the membrane: The membrane was subsequently blocked for a 
minimum of 1 hour using blocking buffer consisting of 100µl Tween 20 (Fisher 
Scientific, UK), 5% non-fat milk (for phospho proteins 3% bovine serum albumin 
(BSA) was used), 10 ml of 10x washing buffer (10mM Tris-Base (pH 7.5) and 
100mM sodium chloride (NaCl; Fisher Scientific, UK)) in a volume of 100 ml. 
Blocking prevents non-specific binding of antibodies to the membrane. 
 
After blocking, the membrane was placed in a sealed hybridization bag in a solution 
containing anti-iNOS monoclonal antibody (BD biosciences, UK) in 1:2500 dilution or 
anti-phospho p38 MAPK (Cell Signalling, UK) in 1:2500 dilution or anti-HO-1 
(Abcam, UK) in 1:250 dilution or anti-phospho Akt (Cell Signalling, UK) in 1:1000 
dilution and anti--actin monoclonal antibody (Sigma-Aldrich, UK)in 1:5000 dilution in 
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blocking buffer prepared on the day of use. The hybridization bag was placed on a 
shaker overnight at 40C. The membrane was washed with x1 washing buffer for 30 
minutes, changing the buffer every 10 minutes and then incubated with the 
secondary antibodies on a shaker for a further 1 hour at room temperature. The 
secondary antibodies were anti-mouse (Cell signalling, UK) in 1:5000dilutions and 
anti-biotin (Cell signalling, UK) diluted 1:1000 in x1 blocking buffer. At the end of this 
incubation, membranes were washed with x1 washing buffer for 1hr, changing the 
buffer for every 10 minutes.  
 
Enhanced chemiluminescence detection (ECL): To identify the protein bands, 
equal volume of ECL detection solution A and B were prepared. Solution A 
contained 100mM Tris pH 8.5, 4.5mM of p-coumaric acid (Sigma-Aldrich, UK) and 
25mM of Luminol (Sigma-Aldrich, UK) and solution B had 100mM Tris pH 8.5 and 
0.02% H2O2. Each membrane was placed on a sheet of cling film in a cassette. The 
detection solution was then pipetted onto the membrane and incubated for 5 minutes 
at room temperature. Excess solution was drained off and the membrane was 
covered with cling film before exposing to an autoradiography film (Fisher Scientific, 
UK). The film was developed using a developer solution (Sigma-Aldrich, UK) until the 
bands appear followed by a rinse with water and fixed in a fixer solution (Sigma-
Aldrich, UK). Finally the film was washed under running water and allowed to dry. 
 
2.8Detection of free radical generation by confocal microscopy: 
Confocal microscopy technique is used to increase optical resolution by using point 
illumination and a pinhole having various sizes that helps to remove out-of-focus light 
in samples. It can be used for three-dimensional reconstructions of images. The 
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microscope signifies a thin cross-section of the specimen and when compared to a 
conventional microscope, it offers a better contrast. In biomedical sciences the major 
application of confocal microscopy involves imaging live or fixed cells and tissues 
that have been treated with one or more fluorescent probes. 
 
A laser is connected which provides excitation light to get very high intensities. The 
laser light is reflected off the dichromatic mirror. The laser then passes through the 
mirrors that are mounted on motors and these mirrors allows scanning the laser 
throughout the sample. The probe in the sample fluoresces and is focused onto the 
detector pinhole aperture. Photomultiplier detector measures the emitted light 
passing through the detector pinhole. The photomultiplier detector is attached to the 
computer, which shows the image of the sample (Figure 11). 
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Figure 2.6 Principal light pathways involved in imaging of the sample in    
Confocal Microscopy 
The figure is taken from Microscopy: the source for microscopy education (web link: 
http://www.microscopyu.com/articles/confocal/confocalintrobasics.html) 
 
Detection of reactive oxygen species (ROS) production using 
dichlorofluorescein (DCF) 
 
The 2’, 7’ -dichlorofluorescein diacetate is a cell-permeable non-fluorescent probe 
and is widely used to quantify cellular OS. The non-fluorescent fluorescein 
derivative, dichlorofluorescein diacetate (DCFH-DA) is converted to DCF after being 
oxidized by various oxidants and emits fluorescence. The emitted fluorescence is 
directly proportional to the amount of free radicals. When the adherent cells are 
treated with the dye, the non-ionic, non-polar DCFH-DA traverses the cell membrane 
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and intracellular esterases hydrolyze it to nonfluorescent DCFH. In the presence of 
ROS, DCFH is readily oxidized to highly fluorescent DCF with excitation/emission 
maxima of 480/530nm. 
 
 A 10mg of 2’, 7’-dichlorofluorescein diacetate (DCFH-DA) was dissolved in 1ml of 
methanol to make a 20.5mM stock of DCFH-DA. 20μM of working solution was 
prepared by diluting 20.5mM stock in phosphate buffered saline (PBS) and added to 
cells, which had been treated under defined conditions. 1ml of 20μM working 
solution was added to the cells grown on Lab-Tek wells and incubated at 370C for 
10-15 minutes protected from light. Excess DCFH-DA was aspirated and the cells 
washed 3 times with 1x PBS with a 5-minute interval between each wash before 
viewing under an electronic confocal laser-scanning microscope. 
 
 
 
Detection of superoxide production using MitoSOXTM Red 
 MitoSOX Red is a novel fluorogenic dye used for highly selective detection of 
superoxide, the most predominant free radical produced by the mitochondria. The 
dye is cell-permeable and targets the mitochondria of the live cells. The O2
-present in 
the mitochondria oxidizes the MitoSOXTMemitting red fluorescence.  MitoSOXTM is 
readily oxidized by superoxide and not by any other ROS/RNS species and its 
oxidation can bethwarted using specific O2
-inhibitor, SOD. It has excitation/emission 
maxima of 510/580nm. 
 
 57 
50µg of the MitoSOXTM dye was dissolved in 13µl of DMSO to make a 5mM stock 
solution which was then diluted further to give a working solution of 5μM in Hank’s 
balanced salt solution (HBSS; Sigma-aldrich, UK). 2ml of the working solution was 
added to the cells grown on Lab-Tek wells and incubated for 10 minutes at 370C 
protected from light. As in the previous experiments, excess dye was aspirated and 
the cells washed 3 times with 1x PBS with a 5-minute interval between each wash 
before viewing under an electronic confocal laser-scanning microscope. 
 
2.9 Real-time quantitative reverse transcriptase polymerase chain reaction 
(qPCR) 
 
 
Polymerase chain reaction (PCR) has become the keystone of the modern molecular 
biology the world over. Real-time PCR is an advanced form of the polymerase chain 
reaction maximizing the benefits of the technique. The real time PCR enables 
sensitive and reproducible quantification of the amplified complimentary 
deoxyribonucleic acid (cDNA) as it occurs in real time. Amplification of DNA creates 
multiple copies of the DNA. There should be enough DNA to be able to be amplified 
so that we get detectable signal for quantification in order to analyse the sample. It 
precisely measures the amount of cDNA at each cycle using a fluorescent probe. A 
thermostable polymerase enzyme is involved in the reaction, which synthesizes a 
complimentary sequence of bases to any single strand of DNA as shown in Figure 
12. The polymerase enzyme amplifies the selected gene in a mixed DNA sample by 
the addition of small pieces of DNA known as primerscomplimentary to the gene of 
interest. These primers enable the DNA sample to bind to the polymerase and begin 
copying the gene of interest.  
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During the PCR process, changes in the temperature are permitted to control the 
action of the polymerase enzyme and efficient binding of primers. The reaction 
initially started by increasing the temperature to 950C where the entire double 
stranded DNA is converted into single strands. The temperature then is reduced to 
600C to enable the primers to bind to its specific gene. Finally the temperature is 
increased to 720C for fast and efficient activity of the polymerase enzyme. This 
temperature change was repeated for 40 cycles. The amount of fluorescence is 
increased correspondingly with the amplification of each DNA molecule and is 
measured during each cycle and plotted over time. The amount of PCR product in 
each cycle is correlated to fluorescence amplification curve, which enables to 
stipulate the starting quantity of target DNA or RNA. The middle of the curve 
symbolises the exponential phase where emitted fluorescence exceed background 
fluorescence. The amount of fluorescence for each sample is represented as cycle 
threshold (Ct), the point or cycle number at which the fluorescence for that sample 
exceeds background fluorescence. The higher the Ct value of that sample the lower 
is the starting quantity of the target DNA as the fluorescence curve exceeds 
background at a later cycle number. Hence lower Ct values represent higher target 
DNA or RNA. 
 
Figure 2.7 DNA polymerase cleaving the green dye from the red 
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Assay 
Isolation of ribonucleic acid (RNA):Cells grown in monolayer were lysed directly in 
the T-25 tissue culture flask using RNA-STAT 60 (1ml per 5-10 x 106 cells; amsbio, 
UK). Cells were completely lysed by repetitive pipetting. The homogenate was 
transferred into eppendorf tubes and allowed to stand for 5 minutes at room 
temperature for complete dissociation of nucleoprotein complexes. 0.2ml of 
chloroform per 1ml of RNA-STAT 60 was added to the tubes and was shaken 
vigorously for few seconds before incubating at room temperature for 2-3 minutes. 
Homogenateswere centrifuged at 12,000g for 15 minutes at 40C. Subsequently the 
homogenate was separated into two phases: a lower red phenol chloroform phase 
and the colorless upper aqueous phase. Ribonucleic acid (RNA) was present solely 
in the aqueous phase whereas the interphase and lower organic phase contains 
DNA and proteins. Ideally the volume of aqueous phase should be around 60% of 
the volume of RNA used for homogenization. Aqueous layer containing RNA was 
separated using a pipette and transferred into fresh Eppendorf tubes. 0.5ml of 
isopropanol per 1ml of RNA-STAT 60 was added to the eppendorfs. Samples were 
stored at room temperature for 10 minutes and then centrifuged at 12,000g for 10 
minutes at 40C. Ribonucleic acid was precipitated in the form of white pellet at the 
bottom of the tube. The supernatant was removed and the pellet was washed with 
75% ethanol by vortexing and subsequent centrifugation at 7500g for 5 minutes at 
40C. 1ml of 75% ethanol per 1ml of RNA-STAT 60 was used. After centrifugation, the 
supernatant was removed and the RNA pellet was briefly air-dried before dissolving 
in about 40μl of autoclaved double distilled water. 
 
 60 
Removal of contaminating DNA from RNA preparation:TURBO DNase treatment 
was used to remove the DNA from RNA preparations. 0.1 volume of 10X TURBO 
DNase buffer was added to the RNA solution. 1μl of TURBO DNase was added to 
the sample and was mixed properly by repetitive pipetting. Samples were then 
incubated on a heat plate at 370C for 30 minutes. After incubation 1μl of DNase 
inactivation reagent was added to the samples and allowed to stand at room 
temperature for 5 minutes with occasional mixing. Samples were centrifuged at 
10,000g for 2 minutes. Colourless supernatants containing RNA were collected into 
clean eppendorf tubes while pellet at the bottom that had DNase inactivation reagent 
were discarded. 
 
Quantification of RNA:Ribonucleic acid (RNA) was quantified using the photometric 
method. 10μl of RNA sample was diluted with 190μl of sterile distilled water. Prior to 
that, blank readings were taken using 200μl of sterile distilled water. Readings of all 
the RNA samples were taken using a bio-photometer and measured in μg/mL. 
 
Reverse transcription of RNA to cDNA:The process enables the conversion of 
RNA to cDNA using a reverse transcriptase enzyme. A high capacity RNA to cDNA 
kit (Applied Biosystems, UK) was used. 2μg of total RNA was required for the 
process and the total volume used for the reaction was 20μl. Samples were prepared 
as follows: 
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Table 3. Preparation of samples for reverse transcription 
 
Component +RT -RT (Control) 
2X RT Buffer 10μl 10μl 
20X Enzyme mix 1μl - 
RNA Sample Up to 9μl Up to 9μl 
Nuclease Free Water Make up to 20μl Make up to 20μl 
Total per reaction 20μl 20μl 
 
 
Master mix preparation: The master mix was prepared by mixing the fluorescent 
dye SYBR green (Applied Biosystems, UK) with forward and reverse primer and 
cDNA of the target gene. Inducible nitric oxide synthase primers usedwere: 5’-
CTGGCTCGCTTTGCCACGGA-3’ (forward primer) and 5’-
GCTGCGACAGCAGGAAGGCA-3’ (reverse primer). A stock of 100μM was prepared 
by diluting the powdered form in autoclaved double distilled water. A working solution 
of 10μM was used for the PCR process. The master mix was prepared as follows: 
10μl SYBR Green + 1μl of forward primer + 1μl of reverse primer + 2μl of cDNA 
sample + 6μl of nuclease free water. 
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Analysis 
The average or mean of the replicates of control, target and reference gene samples 
were calculated.  
 
Mean Control sample CTMean reference gene CT 
 
Mean Target sample CTMean reference gene CT 
 
 
Final standard deviation = √ (S.D of target sample CT)
2 + (S.D of reference gene 
CT)
2 
 
 
 
 
Fold change = 2-CT
 Target Sample 
 
 
 
 
 
 
CT normalised 
CT Target Sample 
CT Target Sample  = CT Target Sample CT normalised 
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2.10 Statistical analysis 
Statistical analysis was carried out using the Graph Pad Prism 5.0. All values are 
expressed as means ± S.E.M of measurement of atleast 3 individual experiments. 
Statistics applied was one-way analysis of variance (ANOVA) followed by Bonferroni 
or Dunnett or Tukey’s as a post-hoc test having a significance at p<0.001, p<0.01 
and p<0.05. 
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3.0 RESULTS 
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3.1 Rat aortic smooth muscle cells 
Rat aortic smooth muscle cells (RASMCs) were taken out of liquid nitrogen, 
transferred into a T-75 flask and grown to confluency using complete growth culture 
medium. Figure 13 represents smooth muscle cells growing as a monolayer in 
culture and characterised by a polygonal and epitheloid shape. Figure 3.1(a) shows 
the cells in the sub-confluent stage of growth 24 hours after transferring into the flask 
from liquid nitrogen. Figure 3.1(b) shows the cells in a confluent stage, which usually 
takes 3-4 days, and ready for the next passageor plating into wellsfor 
experimentation. 
 
 
                  3.1(a)                                           3.1(b) 
 
Figure 3.1Morphology of RASMCs in culture 
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Rat aortic smooth muscle cells were taken out of a cryo vial from liquid nitrogen and 
cultured using growth culture medium and grown to confluency over 3-4 days in a T-
75 flask. The growth medium in the flask was replenished every 2 days. Initial growth 
and the confluent stages were confirmed by observing the cells in flasks under 
aOLYMPUSTM electronic microscope at a magnification of 40x and 100x. Figure 
3.1(a) was taken after 24hrs of transfer from liquid nitrogen and figure 3.1(b)was 
taken after 72hrs when cells were confluent. 
 
 
3.2 Effects of OS inducers on the viability of rat aortic smooth muscle cells 
 
To determine whether OS inducers used in the studies exerted any cytotoxic effects, 
cells were treated with complete culture medium alone or medium containing various 
concentrations of DEM, antimycin A and H2O2 for 24hrs before performing the MTT 
assay as described in the methods (section 2.6). Control cells showed no decrease 
in viability and the metabolism of MTT by these cells was considered as 100% and 
compared to different concentrations ofOS inducers. Diethyl maleate was found to 
be toxic at 50µMcausing a 30-40% decrease inviability of the cells. Lower 
concentrations did not show any statistically significant change in cell viability when 
compared to controls (Figure 3.2).Antimycin A showed no significant decrease in the 
viability of the cells with less than 20% reduction in MTT metabolism observed even 
at the highest concentration of 150µM used (Figure 3.3). Hydrogen peroxide was 
also not cytotoxic at lower concentrations (150µM and 300µM) but caused a 
significant inhibition of MTT metabolism with almost 40-50% decrease in the cell 
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viability at concentrations of 500µM and above (Figure 3.4). There was no change 
observed in the above data when OS inducers were treated with LPS and IFN-. 
 
 
Figure 3.2 Effect of DEM on viability of RASMCs 
 
Confluent monolayers of cells in 96-well plate were treated with different 
concentrations of DEM for 24hrs as described in section 2.6. Following 24hrs 
incubation, cell viability was determined by performing the MTT assay as described 
in the methods. The data is presented as % cell viability with control as a 100%. The 
data represents the means ± S.E.M. of at least three individual experiments. ** 
denote p<0.01 when compared to control. 
 
 68 
 
 
Figure 3.3 Effect of Antimycin A on viability of RASMCs 
 
Confluent monolayers of cells in 96-well plate were treated with different 
concentrations of antimycin A for 24hrs as described in section 2.6. Following 24hrs 
incubation, cell viability was determined by performing the MTT assay as described 
in the methods. The data is presented as % cell viability with control as 100%. The 
data represents the means ± S.E.M. of at least three individual experiments.  
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Figure 3.4 Effect of H2O2on viability of RASMCs 
 
Confluent monolayers of cells in 96-well plate were treated with different 
concentrations of H2O2for 24hrs as described in section 2.6. Following 24hrs 
incubation, cell viability was determined by performing MTT assay as described in 
the methods. The data is presented as % cell viability with control as 100%. The data 
represents the means ± S.E.M. of at least three individual experiments. *** denote 
p<0.001 when compared to control. 
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3.3 Effects of ethanol on nitrite production and iNOS expression in control and 
activated RASMCs 
 
Because ethanol was routinely used as the solvent for dissolving drugs, experiments 
were carried out to determine whether it had any direct effects on nitrite production 
and iNOS expression. Cells were therefore pre-treated with different concentrations 
of ethanol (0.005%-0.1%) for 30 minutes before activating with LPS (100 µg/ml) and 
IFN- (100 U/ml) for 24hrs as described in the methods (section 2.2.1). Nitrite 
production was estimated using the Griess assay and iNOS expression by western 
blotting as described in the methods (section 2.3 and section 2.7). Control cells 
showed no iNOS expression (figure 3.6) ornitrite production (figure 3.5) but cells 
treated with LPS and IFN- showed clear expression of iNOS and significant 
generation of NO. Treatment with various concentrations of ethanol in the presence 
of LPS and IFN-did not change the expression of iNOS or nitrite production when 
compared to the levels detected in LPS and IFN-treated cells. 
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Figure 3.5 Effects of ethanol on nitrite production in LPS and IFN- activated 
RASMCs 
 
Confluent monolayers of RASMCs in 24-well plate were pre-treated with complete 
culture medium alone or medium containing ethanol (0.005%, 0.01%, 0.05% and 
0.1%) for 30minutes prior to incubation with LPS (100µg/ml) and IFN- (100U/ml) for 
a further 24hrs. Nitrite production was determined as described in the methods 
(section 2.3). The data is expressed as % nitrite production with the response to LPS 
(100µg/ml) + IFN- (100U/ml) taken as 100%. The data represents the means ± 
S.E.M of at least three independent experiments.  
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Figure 3.6 Effects of ethanol on iNOS expression in LPS and IFN- activated 
RASMCs 
Confluent monolayers of RASMCs in 24-well plates were pre-treated with complete 
culture medium alone or medium containing ethanol (0.005%, 0.01%, 0.05% and 
0.1%) for 30minutes prior to incubation with LPS (100µg/ml) and IFN- (100U/ml) for 
a further 24hrs. The expression of iNOS was determined by western blotting as 
described in the methods (section 2.7). The blot is representative of at least three 
independent experiments and the bar graph is the densitometric data expressed as 
% iNOS expression with LPS (100µg/ml) + IFN- (100U/ml) response taken as 
100%. The data represents the means ± S.E.M of at least three independent 
experiments. 
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3.4Effect ofOS inducers on nitrite production in control and activated RASMCs 
 
To determine the effect of OS inducers on nitrite production, cells were pre-treated 
with different concentrations of DEM, antimycin A and H2O2 for 30 minutes before 
incubating the cells with LPS (100 µg/ml) and IFN- (100 U/ml) for 24hrs.Nitrite 
production was determined using theGriess assay as described in the methods 
(section 2.3). Control cells showed no nitrite production. LPS and IFN-induced 
significant generation of nitrite and was considered as the maximum response for 
comparison with OS treated cells. Diethyl maleate caused a concentration 
dependent decrease in NO production, reducing levels by 20%, 30%, 50% and 70% 
at 1µM, 2.5µM, 5µM and 10µM respectively (Figure 3.7) whereas antimycin A 
caused a 40%, 70%, 80% and 90% reduction with 25µM, 50µM, 100µM and 150µM 
respectively (Figure 3.8). In contrast H2O2 (50-300µM) did not cause any inhibition 
and levels of nitrite were found to be similar to thoseof LPS and IFN- alone as 
shown in figure 3.9. 
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Figure 3.7 Effects of DEM on nitrite production in LPS and IFN- activated 
RASMCs 
 
Confluent monolayers of RASMCs in 24-well plates were pre-treated with complete 
culture medium alone or medium containing DEM (1µM, 2.5µM, 5µM and 10µM) for 
30minutes prior to incubation with LPS (100µg/ml) and IFN- (100U/ml) for a further 
24hrs. Nitrite production was determined as described in the methods (section 2.3). 
The data is expressed as % nitrite production with the response to LPS (100µg/ml) + 
IFN- (100U/ml) taken as 100%. The data represents the means ± S.E.M of at least 
three independent experiments.*** denote p<0.001 when compared to LPS 
(100µg/ml) + IFN- (100U/ml). 
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Figure 3.8 Effects of antimycin A on nitrite production in LPS and IFN- 
activated RASMCs 
 
Confluent monolayer of RASMCs in 24-well plate was pre-treated with complete 
culture medium alone or medium containing antimycin A (25µM, 50µM, 100µM and 
150µM) for 30minutes prior to incubation with LPS (100µg/ml) and IFN- (100U/ml) 
for a further 24hrs. Nitrite production was determined as described in the methods 
(section 2.3). The data is expressed as % nitrite production with the response to LPS 
(100µg/ml) + IFN- (100U/ml) taken as 100%. The data represents the means ± 
S.E.M of at least three independent experiments. *** denote p<0.001 when 
compared to LPS (100µg/ml) + IFN- (100U/ml). 
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Figure 3.9 Effects ofH2O2on nitrite production in LPS and IFN- activated 
RASMCs 
 
Confluent monolayer of RASMCs in 24-well plate was pre-treated with complete 
culture medium alone or medium containing H2O2(50µM, 100µM, 150µM and 
300µM) for 30minutes prior to incubation with LPS (100µg/ml) and IFN- (100U/ml) 
for a further 24hrs. Nitrite production was determined as described in the methods 
(section 2.3). The data is expressed as % nitrite production with the response to LPS 
(100µg/ml) + IFN- (100U/ml) taken as 100%. The data represents the means ± 
S.E.M of at least three independent experiments.  
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3.5Effect of OS inducers on the expression of the inducible nitric oxide 
synthase (iNOS) 
 
To determine the effect of OS inducers on the expression of iNOS, cells were pre-
treated with different concentrations of DEM, antimycin A and H2O2 for 30minutes 
before incubating the cells with LPS (100 µg/ml) and IFN- (100 U/ml) for 24hrs as 
described in the methods. After 24hrs, lysates were collected and western blotting 
was performed to determine the expression of iNOS as described in the methods 
(section 2.7). In control cells, there was little or no expression of iNOS. Diethyl 
maleate caused a 15%, 40%, 70% and 90% reduction in the levels of iNOS with 
1µM, 2.5µM, 5µM and 10µM respectively (Figure 3.10) whereas antimycin A caused 
a 10%, 40%, 70% and 80% reduction with 25µM, 50µM, 100µM and 150µM 
respectively (Figure 3.11) when compared to LPS and IFN-alone. Incontrast to DEM 
and antimycin A, and consistent with the nitrite data, H2O2 (50-300µM) failed to 
cause any decrease in the expression of iNOS when compared to LPS and IFN- 
alone as shown in figure 3.12. 
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Figure 3.10 Effects of DEM on iNOS expression in LPS and IFN- activated 
RASMCs 
 
Confluent monolayer of RASMCs in 24-well plates were pre-treated with complete 
culture medium alone or medium containing DEM (1µM, 2.5µM, 5µM and 10µM) for 
30minutes prior to incubation with LPS (100µg/ml) and IFN- (100U/ml) for a further 
24hrs. The expression of iNOS was determined by western blotting as described in 
the methods (section 2.7).The blot is representative of at least three independent 
experiments and the bar graph is the densitometric data expressed as % iNOS 
expression with LPS (100µg/ml) + IFN- (100U/ml) response taken as 100%. The 
data represents the means ± S.E.M of at least three independent 
experiments.***denote p<0.001 when compared to LPS (100µg/ml) + IFN- 
(100U/ml). 
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Figure 3.11 Effects of antimycin A on iNOS expression in LPS and IFN- 
activated RASMCs 
 
Confluent monolayers of RASMCs in 24-well plate were pre-treated with complete 
culture medium alone or medium containing antimycin A (25µM, 50µM, 100µM and 
150µM) for 30minutes prior to incubation with LPS (100µg/ml) and IFN- (100U/ml) 
for a further 24hrs. The expression of iNOS was determined by western blotting as 
described in the methods (section 2.7). The blot is representative of at least three 
independent experiments and the bar graph is the densitometric data expressed as 
% iNOS expression with LPS (100µg/ml) + IFN- (100U/ml) response taken as 
100%. The data represents the means ± S.E.M of at least three independent 
experiments. ***denote p<0.001 when compared to LPS (100µg/ml) + IFN- 
(100U/ml). 
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Figure 3.12 Effects of H2O2on iNOS expression in LPS and IFN- activated 
RASMCs 
 
Confluent monolayers of RASMCs in 24-well plate were pre-treated with complete 
culture medium alone or medium containing H2O2(50µM, 100µM, 150µM and 
300µM) for 30minutes prior to incubation with LPS (100µg/ml) and IFN- (100U/ml) 
for a further 24hrs. The expression of iNOS was determined by western blotting as 
described in the methods (section 2.7). The blot is representative of at least three 
independent experiments and the bar graph is the densitometric data expressed as 
% iNOS expression with LPS (100µg/ml) + IFN- (100U/ml) response taken as 
100%. The data represents the means ± S.E.M of at least three independent 
experiments. 
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3.6 Effect of OS inducers on iNOS mRNA expression in control and activated 
RASMCs 
 
To determine whether OS inducers regulated iNOS expression at the transcriptional 
level, analysis of changes in iNOS mRNA was carried out. In these studies, cells 
were pre-treated with different concentrations of DEM (1-10μM), antimycin A (25-
150μM) orH2O2(50-300μM) for 30 minutes before incubating with LPS (100 µg/ml) 
and IFN- (100 U/ml) for 24hrs. The fold change in iNOS mRNA expression was 
determined by performing real-time PCR as described in the methods (section 2.9). 
Control cells showed little or no iNOS mRNA. Cells treated with LPS and IFN- alone 
showed significant expression of iNOS mRNA and this was considered as maximum. 
Diethyl maleate caused a 20%, 40%, 60% and 70% reductions in LPS and IFN-
induced iNOS mRNAat concentrations of1µM, 2.5µM, 5µM and 10µM respectively 
(Figure 3.13).Antimycin A caused a 50%, 60%, 80% and 90% reduction with 25µM, 
50µM, 100µM and 150µM respectively (Figure 3.14) when compared to LPS and 
IFN- alone. In contrast H2O2 (50-300µM) did not cause any inhibition and the folds 
of iNOS mRNA expression were found to be similar to that of LPS and IFN- alone 
(Figure 3.15). These findings are consistent with the trends reported earlier for iNOS 
expression and NO production. 
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Figure 3.13 Effects of DEM on iNOS mRNA in LPS and IFN- activated RASMCs 
 
Confluent monolayers of RASMCs in T-25 flasks were pre-treated with complete 
culture medium alone or medium containing DEM (1µM, 2.5µM, 5µM and 10µM) for 
30minutes prior to incubation with LPS (100µg/ml) and IFN- (100U/ml) for a further 
24hrs. The levels of iNOS mRNA was determined as described in the methods 
(section 2.9). The data represents the fold change in expression of iNOS mRNA and 
is the means ± S.E.M of at least three independent experiments.*** denote p<0.001 
when compared to LPS (100µg/ml) and IFN- (100U/ml). 
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Figure 3.14 Effects of antimycin A on iNOS mRNA in LPS and IFN- activated 
RASMCs 
 
Confluent monolayers of RASMCs in T-25 flasks were pre-treated with complete 
culture medium alone or medium containing antimycin A (25µM, 50µM, 100µM and 
150µM) for 30minutes prior to incubation with LPS (100µg/ml) and IFN- (100U/ml) 
for a further 24hrs. The levels of iNOS mRNA was determined as described in the 
methods (section 2.9). The data represents the fold change in expression of iNOS 
mRNA and is the means ± S.E.M of at least three independent experiments.*** 
denote p<0.001 when compared to LPS (100µg/ml) and IFN- (100U/ml). 
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Figure 3.15. Effects ofH2O2on iNOS mRNA in LPS and IFN- activated RASMCs 
 
Confluent monolayers of RASMCs in T-25 flasks were pre-treated with complete 
culture medium alone or medium containing H2O2 (50µM, 100µM, 150µM and 
300µM) for 30minutes prior to incubation with LPS (100µg/ml) and IFN- (100U/ml) 
for a further 24hrs. The levels of iNOS mRNA was determined as described in the 
methods (section 2.9). The data represents the fold change in expression of iNOS 
mRNA and is the means ± S.E.M of at least three independent experiments. 
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3.7Effect of OS inducers on free radical generation 
To determine the effect of OS inducers on overall free radical generation, cells were 
treated with DEM (1-10µM), antimycin A (25-150µM) or H2O2 (50-300µM) for 24hrs 
before incubating with the general ROS detecting dye2, 7-dichlorofluorescien (20µM) 
for 10minutes. Cells were then washed with PBS (x1) and viewed under a confocal 
microscope as described in the methods (section 2.8). Control cells showed little or 
no detectable levels of free radicals. All three OS inducers on the other hand caused 
significant generation of free radicals. The highest concentration of each of these OS 
inducers was taken as 100% and compared to the different concentrations used in 
the studies respectively. Diethyl maleate at 10µM caused the maximum effect 
whereas 1µM increased free radical generation by 50-60% when compared to 
control (Figure 3.16). With antimycin A, free radical generation was estimated at30-
40%  when compared to the maximum levels generated with a concentration of 
100µM as shown in figure 3.17. Hydrogen peroxide at 50µM generated 40-50% 
andwhen compared to the maximum 300µM (Figure 3.18). 
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Figure 3.16 Effect of DEM on free radical generation in RASMCs 
 
RASMCs were plated into an8-well Lab-Tek plate at a seeding density of 30-40% 
and grown to 60-70% confluency. Cells were then treated with complete culture 
medium alone or medium containing DEM (1-10µM) for 24hrs. Cells were further 
incubated with 2, 7-dichlorofluorescien (20µM) for 10minutes at 370C, washed with 
PBS (x1) 3 times with 5min each wash and then viewed under aNikonTM TE-
2000confocal laser scanning microscope as described in the methods (section 2.8). 
The photographs are representative of at least 3 individual experiments. The bar 
graph ispresented as the % area of fluorescence with the response to 10µMDEM 
taken as 100%. The data represents the means ± S.E.M of at least three 
independent experiments. *** denote p<0.001 when compared to control. 
Control DEM 1µM DEM 10µM 
100µm 100µm 100µm 
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Figure 3.17 Effect of antimycin A on free radical generation in RASMCs 
 
RASMCs were plated into an 8-well Lab-Tek plate at a seeding density of 30-40% 
and grown to 60-70% confluency. Cells were then treated with complete culture 
medium alone or medium containing antimycin A (25-150µM) for 24hrs. Cells were 
further incubated with 2, 7-dichlorofluorescien (20µM) for 10minutes at 370C, washed 
with PBS (x1) 3 times with 5min each wash and then viewed under a NikonTM TE-
2000 confocal laser scanning microscope as described in the methods (section 2.8). 
The photographs are representative of at least 3 individual experiments. The bar 
graph ispresented as the % area of fluorescence with the response to 
150µMantimycin A taken as 100%. The data represents the means ± S.E.M of at 
least three independent experiments. *** denote p<0.001 when compared to control. 
 
Control Antimycin A 25µM Antimycin A 100µM 
100µm 100µm 100µm 
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Figure 3.18 Effect of H2O2on free radical generation in RASMCs 
RASMCs were plated into an 8-well Lab-Tek plate at a seeding density of 30-40% 
and grown to 60-70% confluency. Cells were then treated with complete culture 
medium alone or medium containing H2O2 (50-300µM) for 24hrs. Cells were further 
incubated with 2, 7-dichlorofluorescien (20µM) for 10minutes at 370C, washed with 
PBS (x1) 3 times with 5min each wash and then viewed under a NikonTM TE-2000 
confocal laser scanning microscope as described in the methods (section 2.8). The 
photographs are representative of at least 3 individual experiments. The bar graph is 
presented asthe % area of fluorescence with the response to 300µM H2O2taken as 
100%. The data represents the means ± S.E.M of at least three independent 
experiments. *** denote p<0.001 when compared to control. 
 
Control H2O2 50µM H2O2 100µM 
100µm 100µm 100µm 
 89 
3.8 Time dependent induction of free radical generation by OS inducers 
 
To determine the time and onset of free radical generation, cells were treated with 
DEM (10µM), antimycin A (100µM) or H2O2 (300µM) for 1min, 5min, 15min, 30min, 
1hr, 3hr and 6hr before incubating the cells with2, 7-dichlorofluorescien (20µM) for 
10minutes at 370C. Cells were then washed with PBS (x1) and viewed under the 
confocal microscope as described in the methods (section 2.8). Control cells 
generated little or no free radicals over the 24hr period. All three OS inducers 
generateddetectable amounts of free radicals at different time points with the 
maximum amounts detected at 6hr. Hence this was considered as the peak and was 
taken as 100% when compared to different time points.Antimycin A caused 
significant (70%) generation of free radicals as early as 5min and reaching a peak at 
6hr (Figure 3.19) whereas DEM (Figure 3.20) and H2O2 (Figure 3.21) caused 40% 
and 20% generation of free radicals respectively at 5min but increasing over time to 
reach a peak at 6hr. Of the three agents, antimycin A generated 30% more free 
radicals as early as 5min when compared to DEM or H2O2 suggesting that it was 
quick and more effective at inducing free radical production. 
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Figure 3.19 Time dependent induction of free radical generation in RASMCs by 
antimycin A 
 
*** 
Control 15min 30min 5min 
1hr 3hr 6hr 
Scale bar - 50µm 
 91 
 
 
RASMCs were plated into an 8-well Lab-Tek plateat a seeding density of 30-40% 
and grown to 60-70% confluency. Cells were thentreated with complete culture 
medium alone or medium containing 100µM antimycin A for 5min, 15min, 30min, 
1hr, 3hr and 6hr. Cells were further incubated with 2, 7-dichlorofluorescien (20µM) 
for 10minutes at 370C, washed with PBS (x1) 3 times with 5min each wash and then 
viewed under a NikonTM TE-2000 confocal laser scanning microscope as described 
in the methods (section 2.8). The photographs are representative of at least 3 
individual experiments. The bar graph ispresented as % area of fluorescence with 
the response to 6hr time point taken as 100%. The data represents the means ± 
S.E.M of at least three independent experiments. *** denote p<0.001 when 
compared to control. 
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Figure 3.20Time dependent induction of free radical generation in RASMCs by 
DEM 
 
 
*** 
1hr 3hr 6hr 
Control 5min 30min 15min 
Scale bar - 50µm 
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RASMCs were plated into an 8-well Lab-Tek plateat a seeding density of 30-40% 
and grown to 60-70% confluency. Cells were then treated with complete culture 
medium alone or medium containing5µM DEM for 5min, 15min, 30min, 1hr, 3hr and 
6hr. Cells were further incubated with 2, 7-dichlorofluorescien (20µM) for 10minutes 
at 370C, washed with PBS (x1) 3 times with 5min each wash and then viewed under 
a NikonTM TE-2000 confocal laser scanning microscope as described in the methods 
(section 2.8). The photographs are representative of at least 3 individual 
experiments. The bar graph is presented as % area of fluorescence with the 
response to 6hr time point taken as 100%. The data represents the means ± S.E.M 
of at least three independent experiments. *** denote p<0.001 when compared to 
control. 
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Figure 3.21Time dependent induction of free radical generation in RASMCs by 
H2O2 
 
 
*** 
Control 5min 15min 30min 
1hr 3hr 6hr 
Scale bar - 50µm 
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RASMCs were plated into an 8-well Lab-Tek plateat a seeding density of 30-40% 
and grown to 60-70% confluency. Cells were then treated with complete culture 
medium alone or medium containing 300µM H2O2for 5min, 15min, 30min, 1hr, 3hr 
and 6hr. Cells were further incubated with 2, 7-dichlorofluorescien (20µM) for 
10minutes at 370C, washed with PBS (x1) 3 times with 5min each wash and then 
viewed under a NikonTM TE-2000 confocal laser scanning microscope as described 
in the methods (section 2.8). The photographs are representative of at least 3 
individual experiments. The bar graph is presented as % area of fluorescence with 
the response to 6hr time point taken as 100%. The data represents the means ± 
S.E.M of at least three independent experiments. *** denote p<0.001 when 
compared to control. 
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3.9Induction of superoxide radicals by OS inducers 
The data presented above show that all three OS inducers generated significant 
amount of free radicals but as 2, 7-dichlorofluoresciendoes not distinguish between 
ROS species, further experiments were carried out usingthe novel fluorogenic 
dyeMitoSOX red, which is oxidised specifically by superoxide radicals. Cells were 
treated with DEM (10µM), antimycin A (100µM) or H2O2 (300µM) for 24hrs before 
incubating with MitoSOX red (5µM) for 10minutes. Cells were then washed with 
Hank’s balanced salt solution (HBSS) 3 times before viewing under the confocal 
microscope as described in the methods (section 2.8).Superoxide radical production 
was at low basal levels in control cells but significantly induced by bothantimycin A 
(100µM) and by DEM (10µM), the latter inducing ~70% of the levels detected with 
antimycin A as shown in figure 34. Interestingly, H2O2 (300µM) initiated relatively little 
(15%) superoxide radical when compared to antimycin A (Figure 3.22).  
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Figure 3.22Induction of superoxide radicals by OS inducersin cultured 
RASMCs 
 
 
 
 
 
 
 
 
100µm 
100µm 
100µm 
100µm 
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RASMCs were seeded into a 12-well plate at 30-40% confluency and grown to 50-
60% confluency. Cells were then treated with complete culture medium alone or 
medium containing DEM (10µM), H2O2 (300µM) orantimycin A (100µM) for 24hrs. 
Cells were further incubated with MitoSOX for 10minutes and washed with HBSS 3 
times with 5minutes interval between washes before viewing under the a NikonTM 
TE-2000 confocal laser scanning microscope as described in the methods (section 
2.8). The photographs are representative of at least 3 individual experiments. The 
bar graph ispresented as % area of fluorescence with the response to antimycin A 
(100µM) taken as 100%. The data represents the means ± S.E.M of at least three 
independent experiments. *** denote p<0.001 when compared to control. 
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3.10EffectofPolyethylene glycol-superoxide dismutase (PEG-SOD)on 
superoxide radical generation in the presence and absence ofOS 
inducers 
 
To establish that OS inducers did indeed induce O2
- production, further experiments 
were carried out using the cell permeable O2
-scavenger, PEG-SOD. Cells were pre-
treated with PEG-SOD (500 U/ml)for 30minutes before incubating with DEM (10µM), 
antimycin A (100µM) or H2O2(300µM) for another 30minutes. Cells were then further 
treated with MitoSOX red (5µM) for 10minutes at 370C, washed with HBSS 3 times 
with 5minuteseach wash before viewing under the confocal microscope as described 
in the methods (section 2.8). Control cells and cells treated with de-ionised water or 
PEG-SOD (500 U/ml) did not generate any superoxide radical whereas DEM (10µM) 
and antimycin A (100µM) but not H2O2 (300µM) induced significant amount of 
superoxide radical. Pre-treatment with PEG-SOD (500 U/ml) significantly inhibited 
superoxide radical generation induced by either antimycin A or DEM reducing the 
latter by30-40% and that by antimycin A by 40% (Figure 3.23). 
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Figure 3.23 Effect of PEG-SOD on superoxide radical generation in the 
presence of OS inducers in RASMCs 
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RASMCs were seeded into a 12-well plate at 30-40% confluency and grown to 50-
60% confluency. Cells were then treated with complete culture medium aloneor 
medium containing PEG-SOD (500U ml-1) for 30 minutes prior to incubation with 
DEM (10µM), H2O2 (300µM) and antimycin A (100µM) for 24hrs. Cells were further 
incubated with MitoSOX for 10minutes and washed with HBSS 3 times with 
5minutes interval between washes before viewing under a NikonTM TE-2000 confocal 
laser scanning microscope as described in the methods (section 2.8). The 
photographs are representative of at least 3 individual experiments. The bar graph is 
presented as% area of fluorescence with the response to antimycin A (100µM) taken 
as 100%. The data represents the means ± S.E.M of at least three independent 
experiments. * denote p<0.05 and ** denote p<0.01 when compared to DEM and 
antimycin A with or without PEG-SOD. 
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3.11 Effect of Polyethylene glycol-catalase (PEG-catalase)on superoxide 
radical generation in the presence and absence ofOS inducers 
 
 
In addition to PEG-SOD, experiments were carried out using the cell permeable OH- 
scavenger,PEG-catalase to determine whether part of the signal detected could be 
mediated by OH-.Cells were pre-treated with PEG-catalase (500 U/ml) for 30minutes 
before incubating the cells with DEM (10µM), antimycin A (100µM) or H2O2(300µM) 
for a further 30minutes. Cells were then further treated with MitoSOX red (5µM) for 
10minutes at 370C, washed with HBSS 3 times before viewing under the confocal 
microscope as described in the methods (section 2.8). As already reported for PEG-
SOD, control cells and cells treated with de-ionised water or PEG-catalase (500 
U/ml) did not generate any superoxide radical whereas DEM (10µM) and antimycin A 
(100µM) but not H2O2 (300µM) induced significant amount of superoxide radical. 
Antimycin A alone was taken as 100% as it caused maximum generation of 
superoxide radical. Interestingly, pre-treatment with PEG-catalase (500 U/ml) altered 
ROS production by all three OS inducers but this effect was less significant for DEM 
when compared to antimycin A or H2O2(Figure 3.24). 
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Figure 3.24 Effect of PEG-catalase on superoxide radical generation in the 
presence of OS inducers in RASMCs 
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RASMCs were seeded into a 12-well plate at 30-40% confluency and grown to 50-
60% confluency. Cells were then treated with complete culture medium alone or 
medium containing PEG-CAT (500U ml-1) for 30 minutes prior to incubation with 
DEM (10µM), H2O2 (300µM) and antimycin A (100µM) for 24hrs. Cells were further 
incubated with MitoSOX for 10minutes and washed with HBSS 3 times with 
5minutes interval between washes before viewing under a NikonTM TE-2000 confocal 
laser scanning microscope as described in the methods (section 2.8). The 
photographs are representative of at least 3 individual experiments. The bar graph is 
presented as area of fluorescence with the response to antimycin A (100µM) taken 
as 100%. The data represents the means ± S.E.M of at least three independent 
experiments. ** denote p<0.01 when compared to H2O2 and antimycin A with or 
without PEG-catalase. 
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3.12 Effectofpolyethylene glycol-superoxide dismutase (PEG-SOD) on 
nitriteproduction in the presenceandabsenceof OS inducers 
 
Since O2
- appear to be a major ROS generated by DEM and antimycin A, studies 
were carried out to determine the effect of PEG-SOD on the ability of the OS 
inducers to regulate nitrite production.Cells were pre-treated with PEG-SOD (500 
U/ml) for 30minutes before incubating with DEM (10µM), antimycin A (100µM) or 
H2O2(300µM) for a further 30minutes. Cells were then activated with LPS (100 
µg/ml) and IFN- (100 U/ml) for 24hrs as described in the methods (section 2.2.3). 
Nitrite production was estimated using Griess assay. Control cells and cells treated 
with PEG-SOD alone did not produce any detectable levels of nitrite. Cells treated 
with LPS and IFN- induced significant amounts of nitrite and the responses were 
taken as 100%. In the presence of LPS and IFN-PEG-SOD caused a small but 
significant increase in nitrite production and de-ionised water used, as the vehicle did 
not alter the LPS and IFN- responses. Antimycin A (100µM) and DEM (10µM) but 
not H2O2(300µM) caused significant reductions in the levels of LPS and IFN- 
induced nitrite production as already reported earlier. These reductions were partially 
reversed by PEG-SOD at 500 U/ml (Figure 3.25). Cells treated with H2O2(300µM) in 
the presence or absence of PEG-SOD 500 U/ml did not affect nitrite production 
when compared to LPS and IFN- alone (Figure 3.25). 
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Figure 3.25 Effect of PEG-SOD on nitrite production in the presence and 
absence of OS inducers in LPS and IFN- activated RASMCs 
 
Confluent monolayers of RASMCs in 24-well plate were pre-treated with complete 
culture medium alone or medium containing PEG-SOD (500U/ml) for 30minutes prior 
to incubation with DEM (10µM), antimycin A (100µM) and H2O2(300µM) for a further 
30minutes. Cells were then activated with LPS (100µg/ml) and IFN- (100U/ml) for 
24hrs. Nitrite production was determined as described in the methods (section 2.3). 
The data is expressed as % nitrite production with the response to LPS (100µg/ml) + 
IFN- (100U/ml) taken as 100%. The data represents the means ± S.E.M of at least 
three independent experiments. * denote p<0.05 and *** denote p<0.001 when 
compared to LPS (100µg/ml) + IFN- (100U/ml). 
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3.13 Effectof polyethylene glycol-catalase (PEG-catalase)on nitriteproduction 
in the presenceandabsenceof OS inducers 
 
 
To determine the effect of PEG-catalase in the presence and absence ofOS inducers 
on nitrite production, cells were pre-treated with PEG-catalase (500 U/ml) for 
30minutes before incubating with DEM (10µM), antimycin A (100µM) or 
H2O2(300µM) for a further 30minutes. Cells were then activated with LPS (100 
µg/ml) and IFN- (100 U/ml) for 24hrs and nitrite production determined using the 
Griess assay as described in the methods (section 2.3). Control cells and cells 
treated with PEG-catalase alone did not produce any detectable levels of nitrite. 
Cells treated with LPS and IFN- alone induced significant amount of nitrite and the 
responses were taken as 100%. In the presence of LPS and IFN-PEG-catalase 
and de-ionised water, used as the vehicle, did not alter the LPS and IFN- 
responses. Antimycin A (100µM) and DEM (10µM) but not H2O2(300µM) caused a 
significant reduction in the levels of LPS and IFN- induced nitrite production as 
already reported earlier. PEG-catalase at 500 U/ml did not cause any change in the 
inhibition of nitrite production caused by DEM (10µM) or antimycin A (100µM) 
(Figure 3.26). Cells treated with H2O2(300µM) in the presence or absence of PEG-
SOD 500 U/ml did not affect nitrite production when compared to LPS and IFN- 
alone (Figure 3.26). 
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Figure 3.26 Effect of PEG-Catalase on nitrite production in the presence and 
absence of DEM and antimycin A in LPS and IFN- activated 
RASMCs 
 
Confluent monolayers of RASMCs in 24-well plate were pre-treated with complete 
culture medium alone or medium containing PEG-catalase (500U/ml) for 30minutes 
prior to incubation with DEM (10µM), antimycin A (100µM) or H2O2(300µM) for a 
further 30minutes. Cells were then activated with LPS (100µg/ml) and IFN- 
(100U/ml) for 24hrs. Nitrite production was determined as described in the methods 
(section 2.3). The data is expressed as % nitrite production with the response to LPS 
(100µg/ml) + IFN- (100U/ml) taken as 100%. The data represents the means ± 
S.E.M of at least three independent experiments.  
 
 
A   
PEG-catalase 500U ml
-1
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3.14 Effectofpolyethylene glycol-superoxide dismutase (PEG-SOD) onthe 
expression of iNOSin the presenceandabsenceof OS inducers 
 
To establish whetherthe effect of PEG-SOD reported above involved regulating 
iNOS expression, additional studies were conducted pre-treating cells with PEG-
SOD (500 U/ml) for 30minutes before incubating with DEM (10µM), antimycin A 
(100µM) or H2O2(300µM) for a further 30minutes. Cells were then activated with LPS 
(100 µg/ml) and IFN- (100 U/ml) for 24hrs as described in the methods. Lysates 
were collected and subjected to western blotting for iNOS expression. Control cells 
and cells treated with PEG-SOD alone did not induce any detectable iNOS 
expression which was seen in cells treated with LPS and IFN- PEG-SOD and de-
ionised water in the presence of LPS and IFN- did not change the expression of 
iNOS when compared to LPS and IFN- alone. Antimycin A (100µM) and DEM 
(10µM) but not H2O2(300µM) caused a significant reduction in LPS and IFN-induced 
iNOS expression as reported earlier. PEG-SOD at 500 U/ml was able to partially 
reverse the inhibition of iNOS expression caused by DEM (10µM) and antimycin A 
(100µM) but this effect was more pronounced with DEM than with antimycin A 
(Figure 3.27). Cells treated with H2O2(300µM) in the presence or absence of PEG-
SOD 500 U/ml did not affect iNOS expression when compared to LPS and IFN- 
alone (Figure 3.27). 
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Figure 3.27 Effect of PEG-SOD on iNOS expression in the presence and 
absence of DEM and antimycin A in LPS and IFN- activated 
RASMCs 
 
 
 
 
 
PEG-SOD 500U ml
-1
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Confluent monolayers of RASMCs in 24-well plate were pre-treated with complete 
culture medium alone or medium containing PEG-SOD (500U/ml) for 30minutes prior 
to incubation with DEM (10µM), antimycin A (100µM) or H2O2(300µM) for a further 
30minutes. Cells were then activated with LPS (100µg/ml) and IFN- (100U/ml) for 
24hrs. The expression of iNOS was determined by western blotting as described in 
the methods (section 2.7). The blot is representative of at least three independent 
experiments and the bar graph is the densitometric data expressed as % iNOS 
expression with LPS (100µg/ml) + IFN- (100U/ml) response taken as 100%. The 
data represents the means ± S.E.M of at least three independent experiments. 
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3.15 Effectofpolyethylene glycol-catalase (PEG-catalase)onthe expression of 
iNOSin the presence andabsenceof OS inducers 
 
 
In parallel studies to the above, cells were pre-treated with PEG-catalase (500 U/ml) 
for 30minutes before incubating with DEM (10µM), antimycin A (100µM) or 
H2O2(300µM) for a further 30minutes. Cells were then activated with LPS (100 
µg/ml) and IFN- (100 U/ml) for 24hrs.Lysates were collected and subjected to 
western blotting to determine the expression of iNOS as described in the methods. 
Control cells and cells treated with PEG-catalase alone did not produce any 
detectable levels of iNOS expression. Cells treated with LPS and IFN- alone 
induced the expression of iNOS and was taken as 100%. PEG-catalase and de-
ionised water in the presence of LPS and IFN- did not change the expression of 
iNOS when compared to LPS and IFN- alone. Antimycin A (100µM) and DEM 
(10µM) but not H2O2(300µM) in the presence of LPS and IFN- caused a significant 
reduction in the expression of iNOS when compared to LPS and IFN-alone. PEG-
catalase at 500 U/ml had no effect on the inhibition of iNOS expression caused by 
DEM (10µM) or antimycin A (100µM). Hydrogen peroxide at 300µM in the presence 
or absence of PEG-catalase (500 U/ml) did not cause any change in the expression 
of iNOS when compared to LPS and IFN-alone as shown in figure 3.28.  
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Figure 3.28 Effect of PEG-Catalase on iNOS expression in the presence and 
absence of DEM and antimycin A in LPS and IFN- activated 
RASMCs 
 
 
 
 
 
 
PEG-catalase 500U ml
-1
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Confluent monolayers of RASMCs in 24-well plate were pre-treated with 
completeculture medium alone or medium containing PEG-catalase (500U/ml) for 
30minutes prior to incubation with DEM (10µM), antimycin A (100µM) or 
H2O2(300µM) for a further 30minutes. Cells were then activated with LPS (100µg/ml) 
and IFN- (100U/ml) for 24hrs. The expression of iNOS was determined by western 
blotting as described in the methods (section 2.7). The blot is representative of at 
least three independent experiments and the bar graph is the densitometric data 
expressed as % iNOS expression with LPS (100µg/ml) + IFN- (100U/ml) response 
taken as 100%. The data represents the means ± S.E.M of at least three 
independent experiments. 
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3.16Effect of atorvastatin on NO production in the presence and absence ofOS 
inducers 
 
As indicated in the introduction, statins have become one of the critical drugs used in 
treating patients with coronary heart disease because of their effective lipid lowering 
effects. However, statins may also have other novel actions, which may be 
independent of their anti-lipidemic actions. In this regard, and of relevance to this 
thesis, statins may also have anti-oxidant properties (Davignon et al., 2004).Thus, 
experiments were carried out to determine whether statins (in particular atorvastatin) 
regulate NO production. To determine whether Atorvastatin exerted any cytotoxic 
effects, cells were treated with complete culture medium alone or medium containing 
various concentrations of Atorvastatinfor 24hrs before performing the MTT assay as 
described in the methods (section 2.6). Control cells showed no decrease in viability 
and the metabolism of MTT by these cells was considered as 100% and compared 
to different concentrations of Atorvastatin. Atorvastatin was found to be toxic at 
100µM causing a 50-60% decrease in cell viability. Lower concentrations did not 
show any statistically significant change in cell viability when compared to controls 
(Figure 3.29). There was no change observed in the above data when Atorvastatin 
was treated with LPS and IFN-.In one series of experiments, cells were pre-treated 
with different concentrations of atorvastatin for 30minutes before incubating with LPS 
(100 µg/ml) and IFN- (100 U/ml) for 24hrs and nitrite production was determined by 
the Griess assay as described in the methods (section 2.3). Control cells showed no 
detectable levels of nitrite while LPS and IFN-induced the expected increase in 
nitrite (Figure41).Atorvastatin alone did not induce nitrite production butenhanced the 
effects of LPS and IFN-causing a bell-shaped response. Nitrite production was 
increased with increasing concentration of atorvastatin starting at 1µM, reaching a 
maximum at 10µMbut there was a marginal decrease at 30µM when compared to 
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LPS (100 µg/ml) and IFN- (100 U/ml) alone (Figure 3.30). Further experiments in 
the presence of OS inducers were conducted using 10µM atorvastatin, which caused 
the maximum increase in nitrite production when used with LPS and IFN-. In these 
experiments cells were treated with 10µM Atorvastatin for 30minutes before 
incubating with DEM (1-10µM), antimycin A (25-150µM) or H2O2(50-300µM) for a 
further 30minutes. Cells were then activated with LPS (100 µg/ml) and IFN- (100 
U/ml) for 24hrs as described in the methods.Once again, control cells showed no 
nitrite whereas LPS and IFN- induced nitriteand this was inhibited in a concentration 
dependent manner by DEM.Atorvastatin at 10µM was able to completely reversethe 
inhibition caused by DEM (1-10µM) (Figure 3.31). Antimycin A also significantly 
inhibited nitrite production in a concentration dependent manner. Treatment with 
10µM atorvastatin significantly reversed the inhibitions in nitrite and this effect was 
more pronounced with the lower (25µM and 50µM) rather than the higher (100 µM 
and 150 µM) concentrations of antimycin A. In each case however, nitrite levels were 
higher than those seen with antimycin A alone (Figure 3.32). Hydrogen peroxide did 
not cause any change in nitrite production with or without 10µM atorvastatin when 
compared to LPS and IFN- alone as seen in figure 3.33. 
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Figure 3.29 Effect of Atorvastatin on viability of RASMCs 
 
Confluent monolayers of cells in 96-well plate were treated with different 
concentrations of Atorvastatin for 24hrs as described in section 2.6. Following 24hrs 
incubation, cell viability was determined by performing the MTT assay as described 
in the methods. The data is presented as % cell viability with control as a 100%. The 
data represents the means ± S.E.M. of at least three individual experiments. *** 
denote p<0.001 when compared to control. 
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Figure 3.30 Effect of atorvastatin on nitrite production in LPS and IFN-
activated RASMCs 
 
Confluent monolayers of RASMCs in 24-well plates were pre-treated with complete 
culture medium alone or medium containing atorvastatin (1µM, 3µM, 10µM, 30µM) 
for 30minutes prior to incubation with LPS (100µg/ml) and IFN- (100U/ml) for a 
further 24hrs. Nitrite production was determined as described in the methods 
(section 2.3). The figure represents % nitrite production with the LPS (100µg/ml) + 
IFN- (100U/ml) response taken as 100%. The data represents the means ± S.E.M 
of at least three independent experiments. ** denote p<0.01 when compared to LPS 
(100µg/ml) + IFN- (100U/ml). 
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Figure 3.31 Effect of atorvastatin on nitrite production in the presence of DEM 
in LPS and IFN- activated RASMCs 
 
Confluent monolayers of RASMCs in 24-well plates were pre-treated with complete 
culture medium alone or medium containing atorvastatin (10µM) for 30minutes prior 
to incubation with DEM (1µM, 2.5µM, 5µM and 10µM). Cells were then activated with 
LPS (100µg/ml) and IFN- (100U/ml) for a further 24hrs. Nitrite production was 
determined as described in the methods (section 2.3). The figure represents % nitrite 
production with the LPS (100µg/ml) + IFN- (100U/ml) response taken as 100%. The 
data represents the means ± S.E.M of at least three independent experiments. * 
denote p<0.05, ** denote p<0.01 and *** denote p<0.001 when compared to LPS 
(100µg/ml) + IFN- (100U/ml) and individual concentrations of DEM with or without 
atorvastatin. 
Atorvastatin (ATV; 10μM) 
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Figure 3.32 Effect of Atorvastatin on nitrite production in the presence of 
antimycin A in LPS and IFN- activated RASMCs 
 
Confluent monolayers of RASMCs in 24-well plates were pre-treated with complete 
culture medium alone or medium containing atorvastatin (10µM) for 30minutes prior 
to incubation with antimycin A (25µM, 50µM, 100µM and 150µM). Cells were then 
activated with LPS (100µg/ml) and IFN- (100U/ml) for a further 24hrs. Nitrite 
production was determined as described in the methods (section 2.3). The figure 
represents % nitrite production with the LPS (100µg/ml) + IFN- (100U/ml) response 
taken as 100%. The data represents the means ± S.E.M of at least three 
independent experiments. * denote p<0.05, ** denote p<0.01 and *** denote p<0.001 
when compared to LPS (100µg/ml) + IFN- (100U/ml) and individual concentrations 
of antimycin A with or without atorvastatin. 
Atorvastatin (ATV; 10μM) 
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Figure 3.33 Effect of Atorvastatin on nitrite production in the presence of 
H2O2in LPS and IFN- activated RASMCs 
 
Confluent monolayers of RASMCs in 24-well plates were pre-treated with complete 
culture medium alone or medium containing atorvastatin (10µM) for 30minutes prior 
to incubation withH2O2(25µM, 50µM, 100µM and 150µM). Cells were then activated 
with LPS (100µg/ml) and IFN- (100U/ml) for a further 24hrs. Nitrite production was 
determined as described in the methods (section 2.3). The figure represents % nitrite 
production with the LPS (100µg/ml) + IFN- (100U/ml) response taken as 100%. The 
data represents the means ± S.E.M of at least three independent experiments.  
 
 
 
 
Atorvastatin (ATV; 10μM) 
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3.17Effectsofatorvastatinon the expression of iNOSin the presence and 
absence of OS inducers 
 
To determine the effect of atorvastatin on iNOS expression in the presence and 
absence of OS inducers, cells were pre-treated with different concentrations of 
atorvastatin for 30minutes before incubating the cells with LPS (100 µg/ml) and IFN-
 (100 U/ml) for 24hrs.Lysates were collected and subjected to western blotting as 
described in the methods. Control cells showed little or no expression of iNOS 
whereas significant induction was seen with LPS and IFN- and this was considered 
as 100% when compared to OS inducers. Similar to nitrite production, atorvastatin 
caused an increase in the expression of iNOS with increasing concentrations starting 
at 1µM, reaching a maximum at 10µM and slightly decreasing at 30µM (Figure 3.34). 
Further experiments were conducted using 10µMatorvastatin in the presence and 
absence of OS inducers as at this concentration there was maximum increase in 
iNOS expression. In experiments with OS inducers, cells were pre-treated with 10µM 
atorvastatin before incubating with DEM (1-10µM), antimycin A (25-150µM) or 
H2O2(50-300µM) for a further 30minutes. Cells were then activated with LPS (100 
µg/ml) and IFN- (100 U/ml) for 24hrs as described in the methods. Diethyl maleate 
caused a concentration dependent inhibition on the expression of iNOS. Atorvastatin 
was able to significantly reduce the inhibition caused by DEM (1-10µM) (Figure 
3.35), completely reversing that seen with 1µMand causing a 20 to 40% reversal of 
the inhibitions seen with 2.5µM, 5µM and 10µMDEM. Antimycin A, similar to DEM, 
significantly inhibited iNOS expression and this was found to be concentration 
dependent (Figure 3.36). Atorvastatin again reversed the inhibitions caused by 
antimycin A and this effect was more pronounced at the lower concentrations of 
antimycin A. Atorvastatincompletely restored the inhibition caused by 25µM whereas 
it caused a 80-90% reversal of the inhibition caused by 50µM,100µM and 150µM 
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antimycin A when compared to antimycin A alone.Consistent with its lack of effect on 
nitrite production, H2O2 did not cause any significant change in iNOS expression with 
or without 10µM atorvastatin when compared to LPS and IFN- alone (Figure 3.37). 
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Figure 3.34 Effect of Atorvastatin on iNOS expression in LPS and IFN- 
activated RASMCs 
 
Confluent monolayers of RASMCs in 24-well plates were pre-treated with complete 
culture medium alone or medium containing atorvastatin (1µM, 3µM, 10µM, 30µM) 
for 30minutes prior to incubation with LPS (100µg/ml) and IFN- (100U/ml) for a 
further 24hrs. The expression of iNOS was determined by western blotting as 
described in the methods (section 2.7). The blot is representative of at least three 
independent experiments and the bar graph is the densitometric data expressed as 
% iNOS expression with LPS (100µg/ml) + IFN- (100U/ml) response taken as 
100%. The data represents the means ± S.E.M of at least three independent 
experiments.** denote p<0.01 and *** denote p<0.001 when compared to LPS 
(100µg/ml) + IFN- (100U/ml). 
iNOS (130KDa) 
β-actin (42KDa) 
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Figure 3.35 Effect of Atorvastatin on iNOS expression in the presence and 
absence of DEM in LPS and IFN- activated RASMCs 
 
Confluent monolayers of RASMCs in 24-well plate were pre-treated with complete 
culture medium alone or medium containing atorvastatin (10µM) for 30minutes prior 
to incubation with DEM (1µM, 2.5µM, 5µM and 10µM) for a further 30minutes. Cells 
were then activated with LPS (100µg/ml) and IFN- (100U/ml) for 24hrs. The 
expression of iNOS was determined by western blotting as described in the methods 
(section 2.7). The blot is representative of at least three independent experiments 
and the bar graph is the densitometric data expressed as % iNOS expression with 
LPS (100µg/ml) + IFN- (100U/ml) response taken as 100%. The data represents the 
means ± S.E.M of at least three independent experiments.** denote p<0.01 and *** 
denote p<0.001 when compared to LPS (100µg/ml) + IFN- (100U/ml) and individual 
concentrations of DEM with or without atorvastatin. 
Atorvastatin (ATV; 10μM)  
iNOS – 130KDa 
 
-actin – 42KDa 
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Figure 3.36 Effect of Atorvastatin on iNOS expression in the presence and 
absence of antimycin A in LPS and IFN- activated RASMCs 
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Confluent monolayers of RASMCs in 24-well plate were pre-treated with complete 
culture medium alone or medium containing atorvastatin (10µM) for 30minutes prior 
to incubation with antimycin A (25µM, 50µM, 100µM and 150µM) for a further 
30minutes. Cells were then activated with LPS (100µg/ml) and IFN- (100U/ml) for 
24hrs. The expression of iNOS was determined by western blotting as described in 
the methods (section 2.7). The blot is representative of at least three independent 
experiments and the bar graph is the densitometric data expressed as % iNOS 
expression with LPS (100µg/ml) + IFN- (100U/ml) response taken as 100%. The 
data represents the means ± S.E.M of at least three independent experiments.*** 
denote p<0.001 when compared to LPS (100µg/ml) + IFN- (100U/ml) and individual 
concentrations of antimycin A with or without atorvastatin. 
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Figure 3.37 Effect of Atorvastatin on iNOS expression in the presence and 
absence of H2O2in LPS and IFN- activated RASMCs 
 
 
 
Atorvastatin (ATV; 10μM) 
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Confluent monolayers of RASMCs in 24-well plate were pre-treated with complete 
culture medium alone or medium containing atorvastatin (10µM) for 30minutes prior 
to incubation with H2O2(25µM, 50µM, 100µM and 150µM) for a further 30minutes. 
Cells were then activated with LPS (100µg/ml) and IFN- (100U/ml) for 24hrs. The 
expression of iNOS was determined by western blotting as described in the methods 
(section 2.7). The blot is representative of at least three independent experiments 
and the bar graph is the densitometric data expressed as % iNOS expression with 
LPS (100µg/ml) + IFN- (100U/ml) response taken as 100%. The data represents the 
means ± S.E.M of at least three independent experiments.*** denote p<0.001 when 
compared to LPS (100µg/ml) + IFN- (100U/ml). 
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3.18 Effect of atorvastatin on superoxide radical generation in the presence 
and absence of OS inducers 
 
To determine whether atorvastatin regulated superoxide radical production by OS 
inducers, cells were pre-treated with atorvastatin (10µM) for 30minutes before 
incubating the cells with DEM (10µM) or antimycin A (100µM) for another 30minutes. 
Cells were then further treated with MitoSOX red (5µM) for 10minutes at 370c, 
washed with HBSS 3 times before viewing under confocal microscope as described 
in the methods (section 2.8). Control cells and cells treated with atorvastatin (10µM) 
alone did not generate any superoxide radical whereas DEM (10µM) and antimycin 
A (100µM) induced significant amount of superoxide radicalas previously reported. 
Antimycin A alone was taken as 100% as it caused maximum generation of 
superoxide radical. Atorvastatin (10µM) caused a 20% reduction in the response to 
DEM whereas with antimycin A, superoxide radicalgeneration was inhibited down to 
almost 30-40%of the induced response as shown in figure 3.38. 
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Figure 3.38 Effect of atorvastatin on superoxide radical generation in the 
presence and absence of OS inducers in RASMCs 
 
RASMCs were seeded into a 12-well plate and was treated with complete culture 
medium alone or medium containing atorvastatin (10µM) for 30 minutes prior to 
incubation with DEM (10µM)orantimycin A (100µM) for 24hrs. Cells were then further 
incubated with MitoSOX for 10minutes before viewing under a NikonTM TE-2000 
confocal laser scanning microscope as described in the methods (section 2.8). The 
photographs are representative of at least 3 individual experiments. The bar graph 
ispresented as% area of fluorescence with antimcyin A (100µM) as 100%. The data 
represents the means ± S.E.M of at least 3 independent experiments. ** denote 
p<0.01 and *** denote p<0.001 when compared to antimycin A or DEM with or 
without atorvastatin. 
 
Atorvastatin (ATV; 10μM) 
*** 
** 
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3.19Effect of OS inducers on the phosphorylation of p38 MAPK 
To begin to understand whether OS regulated the signalling mechanisms that may 
be involved in the expression of iNOS, additional studies were carried out 
investigating the effects of DEM, antimycin A and H2O2on select kinase pathways 
including the p38 MAPK. The latter was selected as a target because of its critical 
involvement in iNOS induction by LPS and IFN- in RASMCs (Baydoun et al., 1999). 
To determine the effect ofOS inducers on the phosphorylation of p38 MAPK, cells 
were pre-treated with DEM (2.5-10µM), antimycin A (50-150µM) or hydrogen 
peroxide (50-300µM) for 30 minutes before activating the cells with LPS (100µg/ml) 
and IFN- (100U/ml) for 24hrs. Lysates were collected and western blotting was 
performed to determine phosphorylation of p38 MAPK expression. Control cells 
showed no expression of phospho-p38 MAPK whereas maximum phosphorylation 
was achieved with LPS and IFN-. In the presence of LPS and IFN-, antimycin A 
caused an 80-90% reduction in the phosphorylation of p38 MAPK whereas DEM 
caused a 60-70% reduction and these effects were found to be concentration 
dependent.On the contrary, H2O2 had lesser effect on the phosphorylation of p38 
MAPK as only 20-30% reduction was observed with higher concentrations of 100µM 
and 300µM as illustrated in figure 3.39. 
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Figure 3.39 Effect of OS inducers on the phosphorylation of p38 MAPK in LPS 
and IFN- activated RASMCs 
 
Confluent monolayers of RASMCs in 24-well plate were pre-treated with complete 
culture medium alone or medium containing DEM (2.5-10µM), antimycin A (50-
150µM) or hydrogen peroxide (50-300µM) for 30minutes. Cells were then activated 
with LPS (100µg/ml) and IFN- (100U/ml) for 24hrs. Phosphorylation of p38 
MAPKwas determined by western blotting as described in the methods (section 2.7). 
The blot is representative of at least three independent experiments and the bar 
graph is the densitometric data expressed as % phospho p38 MAPK expression with 
LPS (100µg/ml) + IFN- (100U/ml) response taken as 100%. The data represents the 
means ± S.E.M of at least three independent experiments.** denote p<0.01 and *** 
denote p<0.001 when compared to LPS (100µg/ml) + IFN- (100U/ml).  
    Phospho p38 – 43KDa 
 
-actin – 42KDa 
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3.20Effect of OS inducers on the phosphorylation of Akt 
Another potential key regulator of LPS and IFN-induced iNOS expression is the PI3-
Akt pathway. Lipopolysaccharides and cytokine stimulates vascular smooth muscle 
cells leading to the activation of PI3-Akt pathway which activates NF-B leading to 
the induction of iNOS (Hattori et al., 2003).To determine the effect of OS inducers 
on the phosphorylation of Akt, cells were pre-treated with DEM (1-10µM), antimycin 
A (25-100µM) or hydrogen peroxide (50-300µM) for 30 minutes before activating the 
cells with LPS (100µg/ml) and IFN- (100U/ml) for 24hrs. Lysates were collected and 
western blotting was performed to determine the phosphorylation of Akt expression 
as described in the methods.Control cells showed no expression of Akt whereas 
maximum phosphorylation was achieved with LPS and IFN- treated cells.Antimycin 
A caused a 30-60% reduction in the phosphorylation of Akt whereas DEM caused a 
50-90% reduction when compared to LPS and IFN-response and these effects were 
found to be concentration dependent. H2O2 had lesser effect on the phosphorylation 
of Akt as only 30% reduction was observed with concentrations of 50-300µM as 
demonstrated in figure 3.40. 
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Figure 3.40 Effect of OS inducers on the phosphorylation of Akt in LPS and 
IFN- activated RASMCs 
 
Confluent monolayers of RASMCs in 24-well plate were pre-treated with complete 
culture medium alone or medium containing DEM (1-10µM), antimycin A (25-100µM) 
or hydrogen peroxide (50-300µM) for 30minutes. Cells were then activated with LPS 
(100µg/ml) and IFN- (100U/ml) for 24hrs. Phosphorylation of Akt was determined by 
western blotting as described in the methods (section 2.7). The blot is representative 
of at least three independent experiments and the bar graph is the densitometric 
data expressed as % phospho Akt expression with LPS (100µg/ml) + IFN- 
(100U/ml) response taken as 100%. The data represents the means ± S.E.M of at 
least three independent experiments.** denote p<0.01 and *** denote p<0.001 when 
compared to LPS (100µg/ml) + IFN- (100U/ml). 
  Phospho Akt – 60KDa 
 
-actin – 42KDa 
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3.21Effect of Atorvastatin on the phosphorylation of p38 MAPK in the presence 
and absence of different concentrations of DEM or antimycin A 
 
To determine the effect of atorvastatin on the phosphorylation of p38 MAPK in the 
presence of DEM or antimycin A, cells were pre-treated with atorvastatin (10µM) for 
30 minutes before incubating the cells with DEM (1-10µM) or antimycin A (25-
150µM) for a further 30 minutes. Cells were then activated with LPS (100µg/ml) and 
IFN- (100U/ml) for 24hrs. Phosphorylation of p38 MAPK was determined using 
western blotting as described in the methods. Control cells and cells treated with 
atorvastatin alone did not cause any phosphorylation of p38 MAPK. LPS and IFN- 
alone induced phosphorylation of p38 MAPK and was considered as maximum. 
Atorvastatin slightly alteredLPS and IFN-induced phosphorylation of p38 MAPK. In 
contrast, antimycin A concentration dependently inhibited the phosphorylation of p38 
MAPK which was reversed by atorvastatin, but this was only partial at the higher 
concentrations of 100µM and 150µM antimycin A (Figure 3.41).As seen with 
antimycin A, DEM concentration dependently inhibitedLPS and IFN- induced 
phosphorylation of p38 MAPK. Atorvastatin at 10µM completely reversed the 
inhibitions caused by 1µM and 2.5µM of DEMand only partially reversed that seen 
with 5µM but had no effect on the inhibitions caused by 10µMDEM (Figure 3.42).  
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Figure 3.41 Effect of Atorvastatin on the phosphorylation of p38 MAPK in the 
presence and absence of Antimycin A in LPS and IFN- activated 
RASMCs 
 
Confluent monolayers of RASMCs in 24-well plate were pre-treated with complete 
culture medium alone or medium containing atorvastatin (10μM) before incubating 
the cells with antimycin A (25-100µM) for a further 30minutes. Cells were then 
activated with LPS (100µg/ml) and IFN- (100U/ml) for 24hrs. Phosphorylation of p-
38 MAPKwas determined by western blotting as described in the methods (section 
2.7). The blot is representative of at least three independent experiments and the bar 
graph is the densitometric data expressed as % phospho p38 MAPK expression with 
LPS (100µg/ml) + IFN- (100U/ml) response taken as 100%. The data represents the 
means ± S.E.M of at least three independent experiments. ** denote p<0.01 and *** 
denote p<0.001 when compared to LPS (100µg/ml) + IFN- (100U/ml) and individual 
concentrations of antimycin A with or without atorvastatin 
KDaPhospho p-38 - 43 
KDa 
- 42 KDa 
Atorvastatin 10μM 
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Figure 3.42 Effect of Atorvastatin on the phosphorylation of p38 MAPK in the 
presence and absence of DEM in LPS and IFN- activated RASMCs 
 
Confluent monolayers of RASMCs in 24-well plate were pre-treated with complete 
culture medium alone or medium containing atorvastatin (10μM) before incubating 
the cells with DEM (1-10µM) for a further 30minutes. Cells were then activated with 
LPS (100µg/ml) and IFN- (100U/ml) for 24hrs. Phosphorylation of p-38 MAPKwas 
determined by western blotting as described in the methods (section 2.7). The blot is 
representative of at least three independent experiments and the bar graph is the 
densitometric data expressed as % phospho p38 MAPK expression with LPS 
(100µg/ml) + IFN- (100U/ml) response taken as 100%. The data represents the 
means ± S.E.M of at least three independent experiments. * denote p<0.05, ** 
denote p<0.01 and *** denote p<0.001 when compared to LPS (100µg/ml) + IFN- 
(100U/ml) and individual concentrations of DEM with or without atorvastatin. 
Phospho p-38 - 43 KDa 
β-actin - 42 KDa 
Atorvastatin 10μM 
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3.22Effect of Atorvastatin on the phosphorylation of Akt in the presence and 
absence of different concentrations of DEM or antimycin A 
 
To determine the effect of atorvastatin on theinhibition of Akt phosphorylation caused 
by DEM or antimycin A, cells were pre-treated with atorvastatin (10µM) for 30 
minutes before incubating the cells with DEM (1-10µM) or antimycin A (25-150µM) 
for a further 30 minutes. Cells were then activated with LPS (100µg/ml) and IFN- 
(100U/ml) for 24hrs and lysates subjected to western blotting as described in the 
methods.Control cells and cells treated with atorvastatin alone did not cause any 
phosphorylation of Akt. LPS and IFN- induced phosphorylation of Akt, which was 
not significantly altered by atorvastatin, but the latter did reverse the concentration 
dependent inhibitions of Akt phosphorylation caused by antimycin A. The effects 
observed were, however, only partial at the higher concentrations of 100µM and 
150µM antimycin A (Figure 3.43). Similarly, the inhibitions caused by DEM were also 
partially reversed by atorvastatin and the effects were significantly above the 
responses seen with DEM alone (Figure 3.44). 
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Figure 3.43 Effect of Atorvastatin on the phosphorylation of Akt in the 
presence and absence of antimycin A in LPS and IFN- activated 
RASMCs 
 
Confluent monolayers of RASMCs in 24-well plate were pre-treated with complete 
culture medium alone or medium containing atorvastatin (10μM) before incubating 
the cells with antimycin A (25-100µM) for a further 30minutes. Cells were then 
activated with LPS (100µg/ml) and IFN- (100U/ml) for 24hrs. Phosphorylation of Akt 
was determined by western blotting as described in the methods (section 2.7). The 
blot is representative of at least three independent experiments and the bar graph is 
the densitometric data expressed as % phospho Akt expression with LPS (100µg/ml) 
+ IFN- (100U/ml) response taken as 100%. The data represents the means ± S.E.M 
of at least three independent experiments. ** denote p<0.01 and *** denote p<0.001 
when compared to LPS (100µg/ml) + IFN- (100U/ml) and individual concentrations 
of antimycin A with or without atorvastatin. 
Phospho Akt = 60 
β-actin = 42 KDaβ-actin 
Atorvastatin 10μM 
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Figure 3.44 Effect of Atorvastatin on the phosphorylation of Akt in the 
presence and absence of DEM in LPS and IFN- activated RASMCs 
 
Confluent monolayers of RASMCs in 24-well plate were pre-treated with complete 
culture medium alone or medium containing atorvastatin (10μM) before incubating 
the cells with DEM (1-10µM) for a further 30minutes. Cells were then activated with 
LPS (100µg/ml) and IFN- (100U/ml) for 24hrs. Phosphorylation of Akt was 
determined by western blotting as described in the methods (section 2.7). The blot is 
representative of at least three independent experiments and the bar graph is the 
densitometric data expressed as % phospho Akt expression with LPS (100µg/ml) + 
IFN- (100U/ml) response taken as 100%. The data represents the means ± S.E.M 
of at least three independent experiments. ** denote p<0.01 and *** denote p<0.001 
when compared to LPS (100µg/ml) + IFN- (100U/ml) and individual concentrations 
of DEM with or without atorvastatin. 
Atorvastatin 10μM 
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4.0 DISCUSSION 
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The studies were initiated to examine the regulation of the expression and function of 
inducible nitric oxide synthase (iNOS) in RASMC’s by OS. As already indicated, the 
role of iNOS in atherosclerosis is controversial. Whilst it is widely believed to have 
detrimental effects and contribute to the pathogenesis of the disease, recent studies 
reveal that iNOS induced NO may have cardio-protective functions in the body, 
which can be helpful in retarding the progression of atherosclerosis (Kanno et al., 
2000; Okazaki et al., 2011).Atherosclerotic lesions are found in intimal layer of the 
artery. These lesions develop due to the endothelial cell injury caused by various 
stimuli as explained before. The centre of the lesion consists of foam cells and 
extracellular lipids, which is surrounded by VSMCs. Vascular smooth muscle cells 
are specialized cells present within the blood vessels and regulates the contraction 
and relaxation of the vessel (Rensen et al., 2007; Wynne et al., 2009). After the initial 
injury the endothelial cells, platelets and inflammatory cells release growth mediators 
and cytokines that causes proliferation and migration of VSMCs leading to plaque 
formation and extracellular matrix deposition. Smooth muscle cells hence are highly 
critical in the pathogenesis of atherosclerosis (Gomez and Owens, 2012). The role of 
iNOS as explained before plays an important role in the pathogenesis of 
atherosclerosis and although different cell types such as neuronal and endothelial 
cells generate iNOS it is the expression of iNOS predominantly in smooth muscle 
cells that may be critical in the pathology. The VSMCs express iNOS to an 
inflammatory response resulting from an injury or infection. Large amounts of NO are 
released from iNOS with potential harmful consequences, which can contribute to 
the pathogenesis of atherosclerosis. Interestingly, emerging evidence now suggest 
that expression of iNOS may act as a compensatory mechanism to the injury caused 
to the vascular wall and in turn prevent the progression of the lesions in 
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atherosclerosis. Hence we studied the activity of iNOS and changes in its expression 
and function in aortic smooth muscle cells in response to OS. The potential 
underlying mechanisms associated with any changes observed were also examined, 
as were the effects of statins, which are rapidly becoming the drugs of choice for 
patients with atherosclerosis.    
 
Our previous preliminary studies have demonstrated that the expression and 
function of iNOS may be selectively down regulated by pro-oxidants such as 
antimycin A andDEM. Inducible nitric oxide synthase induced NO reduces oxidation 
of LDL (Rikitake et al., 1998) and it is possible that the beneficial effects of iNOS-
induced NO may be abolished under conditions of OS. Hence we hypothesized that 
the deleterious effects of OSmay involve suppression of iNOS induced NO thereby 
preventing its protective actions. This may occur through ROS generated during OS 
reacting with NO, thereby decreasing the bioavailability of the latter or, alternatively, 
elements of OS may suppress iNOS expression through regulating the induction of 
this enzyme. Antimycins represent a group of secondary metabolites resulted from 
Streptomyces bacteria. Antimycin A with an empirical formula C28H40O9N2 (Figure 
4.1) prevents the oxidation of ubiquinol by binding to the Qi site of cytochrome c 
reductase during the electron transport chain of oxidative phosphorylation in the 
mitochondria. This leads to the disruption of formation of proton gradient through the 
inner membrane. As a result protons become incapable to stream through the ATP 
synthase complex resulting in inhibition of ATP synthesis. Instead, a large quantity of 
toxic free radical superoxide is formed which causes OS. Antimycin A has been 
extensively used to detect the specific sites of reactive radical species produced in 
mitochondria isolated from skeletal muscle (Huang et al., 2005). 
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Diethyl maleate (DEM) is a maleate ester produced as a result of formal 
condensation of both carboxy groups of maleic acid with ethanol (as shown in figure 
4.2). In organic synthesis, it is generally used as a dienophile for diels-alder type 
cycloaddition reaction. It prevents formation of anti-oxidant gluthathione by inhibiting 
glutathione synthase enzyme(Kaur et al., 2006). As a result there is an increase in 
the pro-oxidant levels causing deleterious effects. Hydrogen peroxide by 
comparisonis a compound with an oxygen-oxygen single bond (as shown in figure 
4.3) and is a colourless liquid having viscosity slightly higher than water. It acts as a 
major factor in free radical associated aging and has an important role as a signalling 
molecule in the regulation of numerous biological processes (Romero and Lamas, 
2014). Hydrogen peroxide is thermodynamically unstable and readily gets converted 
to water and oxygen thus leading to the formation of OH- radical. These OH- radicals 
further damage vital cellular components, especially those of the mitochondria 
causing oxidative DNA impairment (Halliwell et al., 2000). 
 
 
 
Figure 4.1Structural Representation of antimycin A 
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Figure 4.2Structural Representation of diethyl maleate 
 
 
 
 
 
Figure 4.3Structural Representation of Hydrogen Peroxide 
 
Experiments were carried out using each of these agents for comparison. In each 
case cells were pre-incubated with the pro-oxidants: antimycin A, DEM or H2O2.  
Further incubating with LPS and IFN- then subsequently activated the cells and the 
expression of iNOS and NO production were investigated (Wileman et al., 2003). 
These studies revealed antimycin A and DEM showed concentration dependent 
decrease of NO production induced by LPS and IFN- Intriguingly H2O2 was without 
any effect. Antimycin A and DEM but not H2O2 also caused a concentration 
dependent decrease in detectable iNOS protein, suggesting that the suppression of 
NO production was caused by inhibition of iNOS expression.  The results with DEM 
are consistent with the observations made by Kang et al. (1999) showing that DEM 
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inhibits the expression and function of iNOS but in macrophages and hepatocytes. 
Moreover, these findings suggest a relationship between glutathione and the 
induction of iNOS, which may be under critical regulation by cellular glutathione 
levels. With regards to the effects of antimycin A, it is likely that these may be linked 
to ATP depletion in cells. Indeed, ATP production is essential in regulating the 
expression of iNOS during inflammation (Chan et al., 2001). Thus, decreases in the 
levels of iNOS and nitrite could be attributed to the effects of antimycin A in inhibiting 
ATP production. However unlike DEM and antimycin A, H2O2 did not regulate either 
iNOS or nitrite. Our findings with H2O2 further strengthened the available literature 
that supports no change in the expression of iNOS and subsequently nitrite 
production when incubated with H2O2 due to its inability to activate the key signalling 
molecules that leads to the induction of iNOS gene (Thirunavukkarasu et al., 2006; 
Mendes et al., 2003).   
 
In addition to examining the effects of pro-oxidants on iNOS protein expression and 
function, further experiments were also initiated at the transcriptional level by looking 
at the effects of OS inducers on the iNOS mRNA. The results obtained showed a 
similar trend with that seen on iNOS protein expression/function. Antimycin A and 
DEM concentration dependently inhibited the mRNA of iNOS whereas H2O2was 
without any effect when compared to the LPS and IFN- response. This results 
further explains our observations made earlier about the differences in the regulation 
of iNOS by DEM, antimycin A and H2O2. This confirms, at least in our model, that 
H2O2 was not able to effect the iNOS expression and function, as it did not regulate 
the transcription of iNOS gene. This further suggests that the effect may be 
independent of OS or may be specific free radicals generated by OS regulate the 
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signalling cascade that govern the induction of iNOS gene. Also as all three pro-
oxidants generate free radicals, differences can also be attributed to the type of free 
radical species generated. These results strongly indicate that pro-oxidants, or at 
least antimycin A and DEM, regulate the expression of iNOS at the nuclear level, 
potentially regulating gene transcription. This would be consistent with other 
literature reporting that both DEM and antimycin A markedly inhibited LPS induced 
mRNA synthesis for iNOS in hepatocytes and macrophages (Kang et al., 1999) 
which is similar to effects seen in this project on iNOS protein expression and 
function. Interestingly, H2O2 has been reported toup-regulate the expression of iNOS 
through the induction of NF-B and p38 MAPK in macrophages (Aktan, 2004). 
However, as already discussed, H2O2 was without effects in our studies. At present 
these discrepancies cannot be unequivocally explained but it is likely that the effects 
of H2O2 depends on the cell type. As discussed above the H2O2 activates iNOS in 
macrophages and up-regulates iNOS, however it did not affect the NF-B and further 
iNOS in bovine articular chondrocytes and rat islets (Mendes et al., 2003; Cnop et 
al., 2005). This clearly indicates the differential actions of H2O2 in different cell types 
and the effects we have seen in our cell culture model might reflect the same. Also 
H2O2 pre-dominantly generates OH
- radicals compared to DEM and antimycin 
A,which produces high amounts of both O2
- and OH- radicals. Therefore it is likely 
that the pro-oxidants generating O2
- might regulate the expression and function of 
iNOS or the effects might be independent of OS... 
 
Experiments were also conducted to investigate the cytotoxic effects of the selected 
compounds to see whether the above effects observed were specific or a 
consequence of any non-selective cytotoxic action of any of the pro-oxidants. The 
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Results showed no cytotoxic effects with the concentrations used suggesting the 
effects observed were not a related to any cytotoxic effects of antimycin A, DEM 
orH2O2. To additionally rule out any possible direct solvent effects on nitrite 
production and iNOS expression, experiments were also carried out by incubating 
the cells with various concentrations of ethanol. These studies revealed no solvent 
effects at the concentration ranges used, as ethanol alone did not alter nitrite 
synthesis or iNOS expression. Hence the effects reported were due to the treatment 
conditions. 
 
As suggested above the effects seen with the pro-oxidants may or may not be 
independent of OS. Thus, it was essential to establish whether under treatment 
conditions, cells generated free radicals, which may be indicative of OS and may 
contribute to the consequences of OS in the studies. This is particularly important to 
establish especially as H2O2did not cause any detectable changes in any of the 
parameters determined, making it difficult to establish what role OS actually plays in 
suppressing iNOS expression in our cell system or whether the inhibitions observed 
with AA and DEM are a consequence of ROS generation or due to other events 
which can directly or indirectly suppress the NOS gene and thus iNOS expression. 
Generation of ROS was therefore detected by fluorescence when cells were 
exposed to the three pro-oxidants and levels of ROS detected were correlated with 
the degree of inhibition of iNOS expression and NO production. These studies 
enabled us to explore the differences in the actions of H2O2, antimycin A and DEM 
that we have observed previously and establish whether the suppression of iNOS is 
indeed mediated through ROS generation.  
 
 150 
The species and/or site of ROS generation may also be of importance and as a 
result studies were carried out using confocal imaging where cells were loaded with 
an appropriate ROS probes and the reaction of ROS with the selected dye imaged. 
Fluorogenic, chemiluminescent or chromogenic probes such as 2’, 7’ –
dichlorofluorescein (DCFH) and dihydroethidium (DHE) have been extensively used 
in tissue culture experiments to evaluate the production of ROS. The diacetate of 
DCFH (DCFH-DA) is added to cells and is hydrolysed by various intracellular 
esterases to DCFH. Upon oxidation the DCFH is converted to highly fluorescent 
DCF as elucidated in figure 59. Oxidation occurs in the presence of various OS 
molecules present within the cells. Peroxynitrite, the product formed between the 
reaction of NO and superoxide, can also oxidize DCFH (Kooy et al., 1997; Royall 
and Ischiropoulos, 1993). 
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Figure 4.4Structural representation of hydrolysis and oxidation of DCFH 
 
Antimycin A, DEM and H2O2caused significant generation of free radicals when 
incubated with the cells for 24hrs and subsequently probing with the DCF dye. Free 
radical production was found to be concentration dependent. The effects were more 
pronounced with higher concentrations such as 100μM and 150μM for antimycin A; 
5μM and 10μM for DEM and 100μM and 300μM for H2O2. The generation of ROS 
production was time dependent, with all three pro-oxidants inducing free radicals as 
early as 5min and reaching a peak at 6hr. However the effects were more 
pronounced with DEM and antimycin A when compared to H2O2. At early time points 
more amounts of free radicals were generated with DEM and antimycin A compared 
to H2O2. This indicates that DEM and antimycin A were quick to produce good 
amount of free radicals as early as 5min. However all three pro-oxidants generated 
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significant amounts of free radicals at 6hr. These results clearly demonstrate that all 
three pro-oxidants could induce significant levels of free radicals and strongly 
suggest that they may induce OS in our cell system. This however raises the 
question why H2O2 was without any noticeable effects on either iNOS expression or 
on NO production and suggest, to a certain degree, that OS may not regulate iNOS 
or NO production. There is however the alternative hypothesis that the outcome of 
OS may be dependent on the free radical species generated and that O2
-generation 
may impact differently on iNOS and NO when compared to OH- radicals. Thus, to 
further address the differences between these pro-oxidants, studies were extended 
to examine the specific free radicals generated by these agents. As O2
- is the major 
free radical produced during the oxidative burst, experiments were conducted to 
establish the ability of antimycin A, DEM and H2O2 to produce superoxide radical. 
MitoSOX Red, a mitochondrial superoxide indicator and a cationic derivative of 
dihydroethidium, was used as a probe. MitoSOX Red is designed for highly specific 
detection of superoxide in the mitochondria of live cells. Mitochondrial superoxide is 
generated as a by-product of oxidative phosphorylation or by uncoupling of NOS. In 
an otherwise tightly coupled electron transport chain, a few proportion of 
mitochondrial oxygen is partly reduced and these electrons readily react with 
superoxide anion, the predominant reactive oxygen species in mitochondria. As 
explained earlier, uncoupling of NOS due to the deficiency in co-factors such as 
BH4also leads to the generation of O2
- instead of NO thus contributing to the free 
radical accumulation (Kudin et al., 2004; Batandier et al., 2002; Luo et al., 2014). 
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The triphenyl phosphonium constituent of MitoSOX red is responsible for the uptake 
of the dye into the actively respiring mitochondria. Oxidation of the dye by 
superoxide radicals results in the hydroxylation leading to the formation of 2-
hydroxyethidium (as shown in Figure 61), which exhibits fluorescence at a 
wavelength of 400nm that falls in the spectrum of superoxide anion but not of the 
other ROS. Thus this dye enables selective detection of superoxide radical 
(Robinson et al., 2008; Zielonka et al., 2008). 
 
 
 
 
Figure 4.5 Oxidation of MitoSOX to 2-hydroxy-5-(triphenylphosphonium) 
hexylethidium by superoxide (•O2
–). 
 
Cells were incubated with antimycin A, H2O2and DEM for 24hrs and subsequent 
detection of superoxide radical with MitoSOX red. As described in the results, 
antimycin A and DEM produced significant amount of superoxide radical whereas 
hydrogen peroxide did not induce any superoxide radical generation. This data 
suggests the dissimilarities between these pro-oxidants and explains to an extent 
their difference in actions on the expression and function of iNOS. Moreover, these 
findings would suggest that the reduction in the expression of iNOS and consequent 
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inhibition of nitrite production might be achieved by the pro-oxidants that have the 
ability to generate superoxide anion rather than hydroxyl radicals. 
 
To confirm the above proposal, further studies were conducted using specific free 
radical scavengers following treatment of cells with pro-oxidants. Polyethylene glycol 
superoxide dismutase (PEG-SOD) and polyethylene glycol catalase (PEG-catalase) 
were employed as inhibitors, which reduce the levels of superoxide and hydroxyl 
radicals respectively. Polyethylene glycol is covalently linked to superoxide 
dismutase and to catalase to increase the plasma half-life and allow cellular 
penetration thus making these scavengers more effective and long acting. 
Polyethylene glycol superoxide dismutase has been proposed as an effective agent 
for reducing free radical mediated ischemia-reperfusion injury (Galinanes et al., 
1992). It provides protection against O2
-anion by catalysing its oxidation and 
reduction into oxygen and hydrogen peroxide. Polyethylene glycol catalase acts by 
inhibiting OH-radical and reducing H2O2 to water (Parastatidis et al., 2014). 
 
Cells treated with PEG-SOD or with PEG-catalase before incubation with DEM or 
antimycin A revealed that PEG-SOD at 500 U/ml was able to significantly inhibit the 
levels of superoxide generated whereas PEG-catalase only marginally altered the 
levels of superoxide generated by DEM and antimycin A. The marginal effect of 
PEG-catalase is not unexpected as it shows selectivity for hydroxyl radicals. The 
inhibition of superoxide anion by PEG-catalase may however be attributed to its 
effect, albeit small, on the mechanisms by which superoxide anion is produced. In 
this regard, PEG-catalase has been reported to inhibit the angiotensin II system that 
activates the NADPH enzyme, a major source of superoxide anion (Nagata et al., 
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2004). Although there was no angiotensin II used in our studies, PEG-catalase may 
possibly regulate the activation of pathways that lead to the generation of superoxide 
radicals and this, although marginal, could explain to an extent the inhibition of 
superoxide seen in this project.   
 
To confirm the importance of the specific free radical species in inhibiting iNOS 
expression and function, experiments were conducted using PEG-SOD and PEG-
catalase to see if the inhibitions caused by DEM and antimycin A on nitrite 
production and iNOS expression could be restored.  PEG-SOD at 500 U/ml was able 
to partially yet considerably reverse the inhibitions caused by these pro-oxidants, 
thus significantly restoring the expression of iNOS and thus nitrite production.  
However, as the expression of iNOS was already diminished resulting in low protein 
levels, the PEG-SOD could only partially restore the levels of nitrite. PEG-catalase 
did not have any effect on the inhibitions caused by AA and DEM suggesting the 
importance of superoxide anion in regulating the expression and function of iNOS. 
These results confirm the previous effects we have seen with the pro-oxidants in 
differentially regulating superoxide anion production and is consistent with their 
effects on the expression of iNOS and thus nitrite production. 
 
Statins are known to inhibit cholesterol synthesis in the body. These drugs however 
have other beneficial effects apart from their lipid lowering activity. Statins inhibit the 
effects of OS inducers and preserve the protective functions of NO and expression of 
iNOS (Mazzeiet al., 2010). Similarly, in previous studies form our group, atorvastatin 
was shown to reverse the suppression of iNOS by antimycin A and by DEM but 
another statin, pravastatin, was without effect. Thus it is possible that this action of 
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atorvastatin is not common to all statins but perhaps specific to this particular drug or 
other members belonging to the same family of molecules.  
 
Statins are classified into two categories. Natural statins include lovastatin and 
synthetic derivatives include atorvastatin, simvastatin, pravastatin, fluvastatin and 
rosuvastatin. The different types of statins along with their molecular structure are 
shown below: 
 
  
        Atorvastatin                                         cerivastatin  
 
 
 
 
 
 
    Fluvastatin                                                         Lovastatin 
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     Pravastatin                                                simvastatin 
 
Statins prevent the occurrence of cardiovascular diseases by maintaining plaque 
stability, reducing endothelial dysfunction, modulating inflammatory response and 
preventing thrombus formation.Statins are known to raise the quantity of NO through 
the surge in the levels of catalase and tetrahydrobiopterin (BH4)and inhibition of LDL 
oxidation while at the same time restores vitamins C and E levels and endogenous 
antioxidants such as ubiquinone and glutathione. The antioxidant vitamins C and E 
inhibit the oxidative process and may lead to the prevention of atherosclerotic 
lesions. Vitamin C activates NO synthase, stimulates BH4 and reduces endothelial 
dysfunction (Munzelet al., 2005). 
 
Fluvastatin decreases the generation of superoxide and also reduces the 
susceptibility of LDL to oxidation (Kugi et al., 2002). Simvastatin inhibited the 
elevation of thiobarbituric acid and plasma F2-isoprostanes that are the markers of 
OS (Mohamadin et al., 2011). Hence reduction in oxidative molecules can increase 
the bioavailability of NO enhancing its protective actions. Atorvastatin inhibits 
angiotensin-II induced superoxide formation by NADPH oxidase in vascular smooth 
muscle cells (Hong et al., 2006; Pignatelli et al., 2010; Violi et al., 2014). Also, 
atorvastatin has been shown to increase paraoxanase activity and reduce cellular 
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uptake of oxLDL. Paraoxanase is an anti-oxidant enzyme present in HDL. It protects 
plasma lipoproteins from oxidative modification by ROS (Harangi et al., 2004). 
 
Studies were therefore initiated to examine the effects of atorvastatin on the 
expression and function of iNOS. Atorvastatin caused an increase in the expression 
of iNOS and nitrite production in a concentration dependent manner reaching a peak 
at 10μM and then decreasing with further concentrations causing a bell-shaped 
response. Atorvastatin at 10μM appeared to cause a maximum increase in the 
expression and function of iNOS and this concentration was used for further 
experiments. The increase in the expression of iNOS and subsequent nitrite 
production by atorvastatin suggests a possible action at the molecular level. 
Atorvastatin regulate the pathways associated with iNOS expression as evidenced 
by the literature that it activates PI3/Akt kinase and NF-kB, which are essential in 
inducing iNOS expression (Ye et al., 2008; Nakata et al., 2007). Thus, further studies 
were conducted to investigate whether atorvastatin could reverse the inhibitions 
caused by DEM and antimycin A on nitrite production and iNOS expression. 
Atorvastatin significantly restored both nitrite production and iNOS expression 
inhibited by DEM and antimycin A. These results confirm the novel role of 
atorvastatin in restoring the expression and function of iNOS and thus providing a 
protective mechanism against atherosclerosis. 
 
Additional studies examined the effect of atorvastatin on superoxide radical 
generation in the presence and absence of DEM or antimycin A. Atorvastatin at 
10μM significantly inhibited the generation of superoxide radical induced by 
antimycin A and DEM and on its own did not induce any superoxide radical 
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generation above that seen in controls. These results support the potential cellular 
anti-oxidant effects of atorvastatin (Wassmann et al., 2002). 
 
Studies were aimed at understanding the underlying cellular mechanism that 
mediates the suppression of iNOS following treatment of cells with pro-oxidants. In 
this regard, it has been reported that OS regulates various signalling pathways 
including those, which are involved in the transcription of iNOS (Park et al., 2005; 
Schieber and Chandel, 2014). Thus experiments were carried out where changes in 
select kinase signalling were examined under our experimental conditions to 
determine whether pro-oxidants exert effects through suppression of these critical 
pathways. The transcriptional regulation of iNOS has been extensively 
characterised. Many regulatory elements have been identified to be important in LPS 
and IFN- induction of iNOS including the mitogen activated protein kinases 
(MAPKs). These are serine-threonine kinases, which are responsible for activation of 
transcription factors such as activator protein-1 (AP-1) and NF-B (Khalaf et al., 
2010) as shown in figure 4.6. Mitogen activated protein kinases are composed of 
three family members, which are diverse with each other: p38 MAPKs, extracellular 
signal-regulated kinases (ERKs) and c-jun terminal kinases (JNKs) or stress 
activated protein kinases (SAPKs) (Cargnello and Roux, 2011).Mitogen activated 
protein kinasesare activated by MAPK kinases (MKKs), that phosphorylate MAPKs 
on specific threonine and tyrosine residues: MKK4 and MKK7 (also known as JNKK1 
and JNKK2 or SAPK/ERK kinase (SEK)-1 and -2) activate the JNK/SAPKs, MKK3 
and MKK6 activate the p38MAPKs, and MAPK/ERK kinase (MEK)-1 and -2 activate 
the ERKs (Stalheim and Johnson, 2008). Further upstream, JNK and ERK pathways 
were stimulated by the MEK kinases (MEKKs) and other kinases such as germinal 
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center kinase, mixed-lineage kinase, p21-activated kinase, and tyrosine phenol-
lyase. Apart from MAPKs the other pathway involved is Janus kinase/signal 
transducers and activators of transcription (JAK/STAT). It is the principal signaling 
mechanism through which the cytokines and growth factors exert their effects. They 
are involved in cell proliferation, migration, differentiation and apoptosis. The IFN- 
used in our studies activates the JAK/STAT pathway through the receptor interferon-
gamma receptor (IFN- R). The receptor activates the JAK’s which are comprised of 
JAK1, JAK2 and JAK3. The activation of JAKs leads to the phosphorylation of 
downstream targets and its major substrates STAT’s.  STAT’s are present in the 
cytoplasm in an inactivated form. Activation by JAK’s phosphorylates STAT’s into the 
nucleus where it further activates the target genes (Rawlings et al., 2004). STAT’s 
then activate the interferon regulatory factor 1 (IRF-1) which functions as a 
transcription activator for a variety of target genes. Interferon regulatory factor 1 then 
stabilizes the iNOS mRNA in the nucleus leading to the expression of iNOS and 
subsequent NO production (figure 4.6). Some of these kinase pathways were 
investigated in this study but limited to p38 MAPK and Akt because of the restricted 
time available and also because these have been identified as the critical and most 
widely reported signaling pathway for the induction of iNOS. 
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Figure 4.6Schematic Representation of LPS and IFN- Signalling 
 
Cells were treated with DEM, antimycin A or H2O2before activating with LPS and 
IFN-. Antimycin A and DEM but not H2O2 down-regulated the phosphorylation of 
p38 MAPK and this was found to be concentration dependent. These effects were 
similar to the observations we have seen with the OS inducers on the expression of 
iNOS and nitrite production. This confirms the importance of p38 MAPK in regulating 
iNOS expression and, more importantly, tells us that OS regulates the expression 
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and function of iNOS by inhibiting this important signalling molecule. Similar studies 
were also conducted on the phosphorylation of Akt. This signalling molecule was 
found to be upstream to various MAP kinases and its shown to activate downstream 
targets such as NF-kB, AP-1 etc (Kane et al., 2002). Additionally, the literature 
suggests that Akt is predominantly involved in regulating the expression of iNOS by 
activating various signalling molecules that lead to the expression of iNOS (Isenovic 
et al., 2002). Similar to the effects with p38, antimycin A and DEM concentration 
dependently inhibited the phosphorylation of Akt. These studies suggest that DEM 
and antimycin A down-regulate the expression and function of iNOS by inhibiting the 
phosphorylation of both Akt and p38 MAPK, which are the important signalling 
molecules that regulate iNOS. Also H2O2was without any effect because of its 
inability in regulating these signalling molecules. These novel findings confirm the 
difference in OS inducers in regulating iNOS expression. Antimycin A and DEM 
inhibited the iNOS expression/function but not H2O2because of their difference on 
the activity of the key signalling molecules that induce iNOS gene transcription.  
 
Recent studies reveal that there is a link between statins and the protein kinase Akt. 
Low concentrations of Statins enhanced angiogenesis by activating Akt kinase and 
subsequent increase in NO production (Wong et al., 2006).Literature suggests that 
atorvastatin exerted cardio protection through increase in the expression of iNOS 
and subsequently NO production (Zhou et al., 2007). In case of ischaemic pre-
conditioning, atorvastatin activated the transcription of protein kinase C, NF-B and 
JAK-STAT signalling leading to the expression of iNOS. When the activation of iNOS 
is blocked the myocardial infarct size limiting capacity of Atorvastatin was abrogated 
suggesting the need of up-regulation of iNOS in reducing the infarct size (Ye et al., 
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2008; subramani et al., 2009). Atorvastatin improved the endothelial dysfunction and 
vascular tone by scavenging the free radicals and thus reducing the oxidative stress 
(Li et al., 2015; Crespo and Quidgley, 2015). There are various pathways that have 
been suggested through which the Atorvastatin activates iNOS. Of all the pathways, 
MAPKs were considered to be the important pathway through which it regulates the 
expression of iNOS. Atorvastatin phosphorylates Akt leading to the expression of 
downstream targets such as p38 MAPK, NF-B. some studies suggests that 
Atorvastatin at 34-68micromol/L raised the nitrite levels and iNOS activity by 9-fold 
and also increased the mRNA of iNOS (Kolyada et al., 2001; Kesavan et al., 2014). 
These reports gives a strong indication that atorvastatin may be exerting its 
observed effects in our studies by acting, at least in part, on some of the signalling 
identified above. Since we have already identified a role for phospho-p38 and 
phospho-Akt, the next series of experiments examined whether these kinases may 
be regulated by atorvastatin. 
 
Indeed atorvastatin was able to significantly restore the phosphorylation of both p38 
MAPK and Akt inhibited by antimycin A and DEM in a concentration dependent 
manner. These results confirm that atorvastatin suppresses the inhibition caused by 
DEM and antimycin A on nitrite production and iNOS expression by restoring the 
phosphorylation of both p38 MAPK and Akt. Hence these novel and exciting studies 
confirm the importance of Akt and p38 MAPK as the key signalling molecules 
targeted in OS in regulating the expression of iNOS.  Thus by suppressing OS and 
restoring the mechanisms of the iNOS gene transcription we can achieve the desired 
iNOS and nitrite levels and hence help in retarding the progression of atherosclerotic 
lesions. 
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4.1 Summary and Conclusions 
 
The data generated in this thesis showed the difference in the regulation by OS 
inducers on the expression and function of iNOS. The key finding is both DEM and 
antimycin A inhibited iNOS expression and function whereas intriguingly H2O2 was 
without any effect. However all three OS inducers generated significant amount of 
ROS but only DEM and antimycin A produced superoxide anion. The results 
confirms the difference between the three OS inducers and demonstrate clearly that 
effect on iNOS expression/function depends on the ability of the OS inducers to 
generate superoxide anion which may then act at targeted signalling molecules to 
suppress iNOS mRNA and subsequent protein expression. Indeed this was 
confirmed in the second part of the studies which focused on the molecular 
mechanisms through which OS inducers inhibited iNOS expression and function. 
The important findings are the effects of OS inducers on the key signalling 
molecules, p38 MAPK and Akt that regulate the iNOS gene transcription. Both 
antimycin A and DEM inhibited iNOS expression by down-regulating the activation of 
both the p38 MAPK and Akt. These findings further strengthened the importance of 
these signalling molecules in regulating iNOS expression and also revealed a novel 
mechanism by which antimycin A and DEM inhibit the iNOS expression and 
subsequent nitrite production. Also studies conducted using atorvastatin showed an 
increase in the expression of iNOS suggesting an effect at the molecular level. 
Atorvastatin restored the inhibitions caused by OS inducers on the expression of 
iNOS and nitrite production by reversing their effects on key signalling molecules, 
p38 MAPK and Akt.   
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Taken together, the data suggest novel actions for both pro-oxidants and 
atorvastatin, which may have important implications in coronary artery disease 
where suppression of iNOS may be deleterious and maintaining its expression may 
be cardio-protective. 
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5.0FUTURE WORK 
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Further experiments can be carried out by looking at the effects of OS inducers on 
the anti-oxidant signalling molecules and its comparison with the levels of iNOS 
expression and nitrite production. Some of the anti-oxidant signalling molecules and 
transcription factors that can be verified include HO-1, Nrf-2, Klotho etc. 
 
We have looked at the effects of anti-oxidants, PEG-SOD and PEG-catalase, on the 
expression and function of iNOS in the presence and absence of OS inducers. 
Studies can be extended to the signalling mechanisms that regulate the expression 
of iNOS in the presence of OS inducers. These studies can establish whether the 
free radicals such as O2
- and OH-have an effect on key signalling molecules. 
 
Different statins have distinct lipid lowering effects. Hence it would be interesting to 
evaluate the effects of other statins such as simvastatin, cerivastatin, rosuvastatin 
etc. on the iNOS expression/function and also on the signalling pathways following 
treatment of cells with OS inducers. 
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